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SUMMARY
The object of this work was to define the role of surface 
structures of Bordetella pertussis, particularly the fimbrial haemag- 
glutinin (F-HA), in the virulence of the bacteria and in their ability 
to adhere to the epithelium of mouse lung. Preparatory to this, it 
was first necessary to investigate the production of F-HA by different 
strains and under different cultural conditions.
In agreement with recently published work, it was shown 
that B. pertussis produces two haemagglutinins (HA), one of which is 
associated with the toxic factor pertussigen and the other with the 
fimbriae. The F-HA is distinguished from pertussigen in that 
haemagglutination (HA) caused by it is inhibited by cholesterol.
Cells grown in shaken liquid culture showed little evidence 
of F-HA as determined by HA tests and electron microscopy of the 
bacteria.
In static cultures, both the cell-associated and cell-free 
HA were cholesterol-sensitive,and were associated with fimbriae visible 
in the electron microscope.
Highly purified F-HA was obtained by passing the supernate 
of a 5 day static culture through CM-Sepharose CL6B, concentrating the 
eluted protein and adsorbing the F-HA specifically onto cholesterol- 
containing liposomes. This liposome adsorbed protein (LAP) was used 
as a vaccine in mouse protection tests, and to raise specific antiserum. 
The fraction left after adsorbing the F-HA onto the liposomes had a high 
histamine sensitising activity (HSF).
The purified F-HA (LAP) when given to mice intraperitoneally 
(i.p.) two weeks before intracerebral (i.e.) challenge with approximately 
200 LD^Qig of live B. pertussis strain 18323 showed protective properties. 
The fraction with high HSF activity also protected the mice. This HSF
II
or pertussigen fraction was toxic at around 6pg/mouse. Antiserum 
raised against the LAP (F-HA) was also found to protect mice passively 
against i.e. and intranasal (i.n.) challenge.
An adhesion assay for measuring the ability of B. pertussis 
to adhere to (or be retained in) the airways within mouse lungs was 
developed. Adhesion was found to be rapid over the first few minutes 
of. contact, followed by a slower rate and with a maximum level of 
adhesion after 30 rain. C mode, phase IV and large-colony variants of 
B. pertussis, which were of low virulence, showed a low level of 
adhesion to the lungs. There was also difference between strain 
77/18319 which is i.n.-virulent but not i.e.-virulent, and strain 18323 
which is i.e.-virulent but less virulent i.n., in each case there was 
a parallelism between the adhesion levels and lung virulence. This 
may indicate that F-HA and adhesion are more important in lung 
infections than in brain infections of mice.
Although HA by fimbriae was inhibited by cholesterol, 
adhesion and virulence were not inhibited, as judged by failure of 
cholesterol in the bacterial suspension to influence the results of 
these tests. Also cells from 48 h shake cultures were virulent, yet 
were HA-negative. Therefore there does not appear to be a simple 
direct relationship between the presence of fimbriae, as indicated by 
HA, and adhesion and virulence.
In conclusion, it seems that fimbriae are involved in 
adhesion, perhaps by rendering the cells more hydrophobic, although the 
evidence is not fully conclusive. When used as an antigen, fimbriae 
protected mice against both i.n. and i.e. infections, and may therefore 
protect man. Pertussigen was found to be a very potent protective
III
factor against i.e. challenge, and a reliable method for detoxifying 
it should be developed.
It is suggested that a possible improved pertussis vaccine 
for human use might consist of purified F-HA mixed with detoxified 
pertussigen.
IV
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INTRODUCTION
A. Introduction to pertussis
I) A short history
According to Olson (1975) the first written description of 
what is now known as pertussis or Whooping Cough appeared in 1578 when 
an epidemic occurred in Paris (Olson, 1975)o No further accounts 
appeared for almost a century, by which time the disease had become 
ey^.demic in Europe. The word pertussis, meaning a violent cough, was 
first used by Sydenham in 1670o This term is now preferred by many to 
Whooping cough since not all patients with the disease whoop (Lapin,
1943; Olson, 1975)*
Around 1900, Bordet and Gengou (1906) observed coccobacilli 
in such abundance and purity from Bordet's infant daughter suffering , 
from whooping cough that its association with the infection could hardly 
be doubted. A  few years later Bordet and Gengou (1906) described a 
medium suitable for the cultivation of the pertussis bacillus and in a 
series of articles the morphology, cultural characteristics, virulence 
and antigenicity of the organisms and the serological reactions between 
different isolates were described (Bordet & Gengou, 1906, 1907, 1909; 
Bordet & Sleeswyck, 1910), In 1908 and 1909, Klimenko (cited by Lapin, 
1943) reported that he had produced whooping cough in monkeys and 
puppies by inoculation of Bordetella pertussis. There are other reports 
of animal infections, but it was the findings of Williams (1914)^ who 
isolated pure cultures of B, pertussis from many cases of whooping cough, 
that confirmed the etiological significance of Bo pertussis. The 
MacDonalds (MacDonald & MacDonald, 1933) provided direct evidence for 
Bo -pertussis as the causative agent by infecting their own children with 
the organisms and observing the development of typical pertussis in two
of the children* The other two, who had been previously immunised 
with killed bacteria, did not develop the disease»
Bo parapertussis isolated by Eldering & Kendrick (1938) 
has been associated with the pertussis syndrome and, when implicated, 
the infection usually takes the form of a mild case of pertussis.
Although apparently quite rare in the United Kingdom and the U»S,A,,
B, parapertussis contributes much more significantly to pertussis out­
breaks in other parts of the world (Olson, 1975),
Bo bronchiseptica is capable of causing the pertussis 
syndrome but very rarely does so, B, bronchiseptica is, however, the 
cause of a natural respiratory tract infection of rodents and other 
animals (Switzer, Mare & Hubbard, 1966),
There are still doubts that all cases of pertussis are 
necessarily caused -by one of the three Bordetella species; other agents, 
in particular adenoviruses, have been implicated (Olson, 1975),
As noted above, there are three organisms in the genus 
Bordetella, B, pertussis described by Bordet & Gengou (1906) as the 
cause of pertussis, B, parapertussis isolated by Eldering & Kendrick
(1938) also from cases of whooping cough and B. bronchiseptica isolated 
by Ferry (1911) from respiratory tracts of dogs suffering from distemper. 
Bo pertussis and B. parapertussis were initially included in the genus 
Haemophilus while B. bronchisepticOi. had been included in the genus 
Brucella and Alcoligenes, It was Lopez in 1952 who proposed that they 
be collected into a new genus, Bordetella,
Members of the genus Bordetella are small, rod-shaped 
organisms.(0o5-lo0 by 0,3-0,5 jam), arranged singly, in pairs or small 
groups. B. bronchiseptica is flagellate and B, pertussis, when freshly 
isolated, is capsulated, B, pertussis is not dependent on either V or 
X factors, from blood, for growth although complex medium containing
blood is usually used for primary isolation. The optimal growth 
temperature is 35° to 37°C, with no growth anaerobically. The colonies 
are smooth, dome-shaped, and glistening with an entire edge. The 
development of the colonies may take 48 to 72 h, B, pertussis is 
killed at 55°C during 30 min; it ferments no sugars, renders litmus 
milk slightly alkaline, forms catalase but not indole and does not 
reduce nitrates. Haemolysis is observed around the growth on B-G 
medium.
2) Course of the disease in man
Infection occurs mainly by direct contact with patients 
suffering from the disease. The organisms gain access to the body by 
inhalation of material expelled in cough spray. The patient is most 
infectious during the catarrhal stage (Lawson, 1933), There does not 
seem to be any healthy carrier, nor any animal host as far as is known. 
Pertussis is a localised respiratory infection of humans with specific 
manifestations of paroxysmal coughing, lymphocytosis and neurological 
symptoms (Pittman, 1970),
(i) Diagnosis, Diagnosis of the disease is often difficult as 
the true nature may not be evident for a fortnight or so, by which time 
the organisms may have become very difficult to isolate from the naso­
pharynx, For rapid diagnosis, fluorescent antibody can be used and 
according to Limemann et al (1968), offers the same degree of sensitivity 
as cultural techniques.
Cultural diagnosis can be carried out by three methods:
(a) Cough plates, Bordet-Gengou (B-G) medium is coughed onto, 
incubated for 48 to 72 hours and examined for characteristic colonies,
(b) Postnasal or nasopharyngeal swab (Maclean, 1937) onto B-G plates 
with penicillin added to reduce the growth of other organisms.
(c) Pemasal swab (Bradford & Slavin, 1940^
Bo pertussis can be cultivated from such swabs in 60 to 80% of cases 
during the catarrhal stage of the disease*
(ii) Diseaseo After an incubation period of 10 to 16 days 
(Lapin, 1943; Gordon & Hood, 1951; Court e_t al, 1953) there is the 
catarrhal stage which lasts for 1 to 2 weeks and resembles an ordinary, 
upper respiratory tract infection with occasional sneezing, mild cough 
and slight fever. It is during this acute phase that the isolation 
of bacteria is easiest. After the catarrhal stage, the paroxysmal 
stage develops, which is the essence of pertussis* A coughing attack 
consists of a series of forceful coughs, saliva and mucus streaming 
from the nose and mouth* As the final cough appears to clear offending 
secretions or mucus from the upper airway, air rushes into the lungs 
against a still narrowed glottis and the patients can whoop. At the 
end of the paroxysm, patients frequently vomit (Olson, 1975), The 
paroxysmal stage lasts for 1 to 4 weeks but may be prolonged for as long 
as 5 to 6 months (Laurgnce, 1965),
(iii) Lung Pathology. It is difficult to determine the pathology 
of the initial lesion as it is not until later stages, by which time 
the lesions are often complicated by secondary infection, that cases 
come to autopsy* B* pertussis is believed to multiply rapidly on the 
mucus membrane of the respiratory tract causing initially a necrotising 
inflammation of the bronchi, larynx and nasopharyngeal cavity* As 
infection extends to deeper structures, a diffuse bronchopneumonia with 
marked desquamation of the alveolar epithelium develops* A distinctive 
feature is the localisation of the bacteria between the cilia of the 
epithelial cells of the respiratory tract. As infection progresses, 
the bacteria may appear in the alveoli (Pittman, 1970)* Secondary 
complications may occur during the paroxysmal stage which include
haetnorrhagic events, pulmonary complications and, as pertussis broncho­
pneumonia may impair the normal defence mechanisms of the lung, the 
patients (particularly infants) may be vulnerable to other bacterial 
invaders (Strangert, 1970)*
(iv) Neurological complications. Symptoms usually appear at the 
peak of the paroxysmal cough, being found most often in children with 
bronchopneumonia, Zellweger (1959) found that a third of the patients 
showing neurological symptoms fully recover; one third show. , varying 
neurological sequelae and the other third remain incurable. All the 
disorders found concern the brain exclusively and include convulsions, 
coma, paralysis and later epilepsy, mental retardation and other 
disturbances (Nelson, 1939), With the introduction of pertussis 
vaccine, reports of pertussis encephalopathy have been superceded by 
the rare reports of vaccine encephalopathy,
3) Vaccination
The Whooping Gough Immunisation Committee of the Medical 
Research Council conducted controlled trials of different pertussis 
vaccines which gave clear evidence of a substantial order of protection 
(MoR.Co Reports, 1951, 1956), Immunisation with pertussis vaccine was 
practiced nationally in the United Kingdom from 1957 onwards.
Whether the decline in whooping cough since 1957 can largely 
be attributed to immunisation is disputed by some authorities (Dick, 
1975; Bassili & Stewart, 1976) who consider the general improvement in 
the environment and of the welfare of children during these years to 
be more important factors than immunisation in leading to the decline of 
whooping cough.
The vaccine used at present is prepared as whole bacterial 
suspensions and is given in conjunction with diphtheria and tetanus
toxoidso The major difficulty in preparing an entirely satisfactory 
pertussis vaccine is the inability to identify precisely the antigen or 
antigens necessary for the protection of children. Some doctors have 
advocated the withdrawal of pertussis vaccine (Barrie, 1977; Stewart,
1977)o However the Joint Committee on Vaccination and Immunisation 
(JoCoVal., 1977) recommended otherwise, stressing the risk to children 
from pertussis, particularly young infants, and stating that many of the 
reported complications were not specific to the pertussis vaccine. 
Therefore no reliable estimate of the incidence of neurological compli­
cations after pertussis can be made^but the J,C,VoIo evidence supporting 
the continued use of the vaccine,is substantiated by recent data showing 
an increased incidence of whooping cough as the numbers accepting the 
vaccine falls mainly due to the fear of possible brain damage (Stuart- 
Harris, 1979), Fig 1 shows the increase in the number of cases of 
whooping cough in England and Wales particularly in children under 5 
years of age since 1977, This increase in the number of cases of 
whooping cough, probably due to decreased use of the vaccine, illustrates 
the protective effect of the vaccine but also the necessity to produce, 
a safer vaccine more acceptable to parents of young children,
4) Mouse assays for virulence and protective activity
Bo pertussis is not, so far as is known, a natural pathogen 
for any animal other than man. However there have been successful 
infectionS'Of a number of species, including monkeys (Culotta £t al, 1935; 
Sprunt £t 1935; North et al, 1940; Huang _et al, 1962), dogs, 
rabbits (Sprunt eJL 1938) and chicken embryos (Gal la van & Goodpasture, 
1937; Shaffer & Shaffer, 1946), However the mouse has been used more 
extensively than any other species, with three routes of infection being 
adopted.
Fig 1 ; Pertussis quarterly notification rates for
England and Wales.
(Copied from Stuart-Harris, 1979)
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(i) Intraperitoneal (i.p.) - After infection by this route the bacteria 
do not multiply and are killed rapidly* Any lethal effects on the mouse 
are due to toxaemia (Gray, 1946; Proom, 1947),
(ii) Intracerebral (i*c .) - This route was introduced by Kendrick et ^  
(1947). After intracranial injection, the bacteria appear to lodge on 
the ciliated ependymal cells in the ventricle of the brain* There they 
multiply on the ventricle wall giving rise to choroiditis and meningitis 
but there is no evidence of invasion of the bacteria into the substance 
of the brain. The mouse usually dies within 10 days (Berenbaum e_t al,
1960; lida et al, 1962, 1966)* The localisation of organisms is very 
similar to the localisation of bacteria among the bronchial and tracheal 
ciliated epithelial cells in the human infection, I.e.
challenge was shown (M*R*C* 1959) to provide values for mouse protective
potencies of vaccines which correlated fairly well with the human
efficacy of these vaccines. For this reason that third route is prescribed
for the potency assays of pertussis vaccines (W.H*0* 1964),
In ip, infections the virulence of organisms can be divided
into two groups, high virulence and low virulence (Adams, 1970)* Low
virulence strains are much more common and produce only transient
infections even with initial inocula as large as 10^ viable organisms.
The relatively rare high virulence strains are lethal in inocula of as 
3
few as 10 viable organisms* The eradication of low virulence strains 
of B* pertussis from the ventricles seems to be effected by local phago­
cytes (Adams & Hopewell, 1970)* The cells involved in phagocytosis 
and subsequent intracellular bacterial destruction seemed to be the 
ependymal cells and the underlying neuroglia (Hopewell e_t 1972) *
Protection against highly virulent strains of B* pertussis 
in passively or actively protected mice requires the breakdown of the 
blood brain barrier and the leakage of specific gamma globulins into
8
the brain (Dolby & Standfast, 1961). The nature of the antigens 
which protect mice against the lethal effect of intracerebrally virulent 
Bo pertussis is not known. The bactericidal antibody (anti LPS) 
produced in the mouse after vaccination with heat killed bacteria 
(Dolby, 1965; Dolby & Vincent, 1965) was found not to be responsible
for i.e.  protection (Ackers & Dolby, 1972)* The nature of the
i.e. protective antigen is discussed with reference to other
pertussis antigens in section(y ,
(iii) Intranasal (ion.) - Infection of mice by this route results in 
infection of the lung producing a patchy or diffuse interstitial 
pneumonia, leukocytic infiltration around vessels and bronchioles with 
proliferation of the bronchiolar epithelium and mucous secretion in the 
bronchioles containing masses of bacterial (Burnet & Timmins, 1937; 
Bradford, 1938). The histological picture resembles that of the lung 
in human pertussis * Sublethal doses of bacteria increase in number 
for 7 to 14 days (Cooper, 1952; Proom, 1947) and then gradually decline 
but infection may last 3 to 4 weeks (Andersen, 1953; Pittman, 1951; 
Standfast & Dolby, 1961), The duration of infection in the mouse is 
similar to that in the child, and in addition there is leukocytosis 
(Cooper, 1952), Parallelism of duration of histamine sensitivity in 
lung infected mice and of paroxysmal coughing in human infection was 
observed (Pittman, 1951; Geller & Pittman, 1973)* The pathophysio­
logical reactions associated with the respiratory tract infection in 
mice (leukocytesis, hypoglycemia hyperinsulinemia and histamine 
sensitivity, Pittman e_t al, 1980) and those reported in human infections 
(leukocytosis. Cooper, 1952, hypoglycemia, Regan & Tolstoouhov, 1936, 
and the attenuation of epinephrine hyperglycemia, Badr-El-Din ^  al, 
1976) suggest that there is an analogy between the mouse reactions to 
respiratory infection and the clinical course of whooping cough in man.
Although there are close similarities in the mouse lung 
infection and human infections. Standfast (1958) found during MRG trials 
of different vaccines that the immunity response to a lethal in*challenge 
in mice showed little correlation with the protective effect of a vaccine 
in children; the i.e. challenge correlated fairly well. However 
Andersen & Bentzon (1958) found that when using the same highly virulent 
Bo pertussis strain for both i.e. and sublethal i.n, challenge the orders 
of vaccine potencies obtained by the two routes were similar, which was 
not the case when a lethal i.n, dose was used as the challenge,
A recent report (Sato e_t al, 1980) has shown that by 
inoculating mice by aerosol inhalation a predictable and uniform 
respiratory infection with colonization of the lower respiratory tract 
can be accomplished.
Bo In vitro growth of B* pertussis
1) Growth media
The organism that causes whooping cough was first grown on 
artificial media by Bordet & Gengou(1906) This medium 0~G) contains 
glycerinated potato extract and 50% blood. Until Hornibrook (1939) 
described a liquid medium containing amino acids, cysteine and starch,
B-G medium was the only one suitable for the isolation and continued 
cultivation of B, pertussiso With the introduction of Hornibrook*s 
and related media, the growth requirements of B* pertussis and its 
metabolism have been investigated, and various inhibitors of its growth 
identified. The development of solid and liquid media up to 1957 is 
well reviewed by Rowatt (1957),
(i) Solid media. Workers attempting to develop a medium other
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than B-G for the cultivation of Bo pertussis did not realise that cells 
grown, for example, on nutrient agar (Rowatt, 1957) were antigenically 
different from fresh isolates. In 1931, Leslie & Gardner showed that 
freshly isolated strains were antigenically distinct from cells grown 
on simplified media, these cells being phase IV or degenerate strains. 
Several different media were devised (Barksdale & Simpson, 1934; 
Cruickshank & Freeman, 1937; Silverthorne & Cameron, 1942; Dawson 
et al, 1951), none of which were superior to B-G medium.
Pollock (1947) showed that blood in the medium could be 
replaced by serum, serum albumin or charcoal and that isolates maintained 
on such media retained phase I characteristics. He found that growth 
of Bo pertussis was inhibited by unsaturated fatty acids, the inhibition 
being overcome by the inclusion of albumin, charcoal or blood. Liquid
media solidified with agar were not satisfactory for growth of 
B, pertussis unless blood was also added (Verway ejt aT, 1949; Mazloum
& Rowley, 1955), More recently it has been shown that agar itself 
may be inhibitory to the growth of B, pertussis and when a defined solid 
medium was being developed based on the defined liquid medium described 
by Stainer & Scholte (1971), agarose was used as a solidifying agent 
(Parker, 1976), Despite much time and effort being expended in 
attempts to develop better solid media for the isolation and growth of 
B, pertussis, the medium of choice for primary isolation is still B-G 
medium. The solid defined medium of Parker (1976) was developed for 
use mainly in genetic studies of B. pertussis,
(ii) Liquid media. The first liquid medium was that of Hornibrook
(1939), containing hydrolysed casein, starch, salts, cysteine and yeast 
extract. Most liquid media used subsequently have been based on 
Hornibrook's, ‘ In a later modification Hornibrook (1940) replaced the
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yeast extract of the original medium with nicotinamide which is the only 
essential growth factor of B, pertussis yet identified, Cohen & Wheeler 
(1946) modified Hornibrook's medium by increasing the buffering capacity, 
adding ferrous or copper sulphate and increasing the starch content. 
Sutherland & Wilkinson (1961) and Morse & Bray (1969) have further 
modified Cohen & Wheeler (1946) medium. All these liquid media contain 
casein hydrolysate with various salts, growth factors and either starch, 
charcoal or an anionic resin added. By studying the growth requirements 
of B, pertussis several recipes for chemically defined media have been 
devised (Jebb & Tomlinson, 1955, 1957; Wilson, 1963; Goldner et al, 
1966), The semisynthetic medium used by Vajdic ejt aj^  (1966) was 
completely defined apart from a liver co-enzyme preparation but was very 
complex. Stainer & Scholte (1971) published a much simplified defined 
medium giving improved growth yields containing L-proline, L-glutamic 
acid, L-cysteine, salts, Tris*buffer, ascorbic acid, niacin and gluta­
thione.
As well as solid and liquid media necessary for isolation and 
production of bacterial cultures for vaccination and experimental 
infections an ^  vitro growth system which allows specific investigation 
of the mechanisms involved in pathogenicity is useful. One such system 
is that of organ culture,
2) Growth in organ culture
An vitro model, used in studying the pathogenesis of 
B» pertussis is that of infected tracheal organ culture. The technique 
of organ culture permits the maintenance, Ln vitro ,of fragments of organs 
in a viable, organised,differentiated condition, Kendrick e_t (1947) 
successfully demonstrated the i.e. route of infection in mice
but the first reported use of an analogous culture system was that by
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Felton et a_l (1954) where brain tissue was used. Small pieces of human
foetal brain or cat brain in a plasma clot were injected with whole 
bacteria or heat killed bacteria after sufficient growth of the brain 
fragment was observed. Immune serum or normal serum was added to some 
cultures. More tissue damage was observed with live B, pertussis than 
with heat killed organisms and specific antiserum markedly reduced this 
damage whereas normal serum had no protective effect. Damage was 
relatively tissue specific since none was observed in infected chick 
embryo heart muscle, leg muscle or skin and only minimal changes were 
seen in 18 day old chick embryo brain. It has since been shown that 
the apparent tissue specificity resulted from a marked specificity for 
ciliated cells (lida & Ajiki, 1974; Muse £t al^ , 1977),
Carlton (1925) was the first to develop respiratory tract 
organ cultures, but it was not until 1957 that these cultures were used 
to study pathogenicity of microorganisms (Barski e_t aT, 1957). Since 
then organ cultures of respiratory tract have been used in studies of 
virftiL (Hoorn, 1966), mycoplasmal (Collier & Baseman, 1973) and other 
bacterial infections (Denny, 1974),
The respiratory tract is kept almost sterile by the 
defence mechanisms of the host, but some organisms including B. pertussis 
colonise the mucous membranes of the respiratory tract. Tracheal organ 
cultures have been utilised by several workers to study the local 
circumstances of B, pertussis infection.
Holt (1972) demonstrated adhesion of B, pertussis to monkey 
tracheal organ cultures after spraying the organisms through tracheal 
rings. He also showed that immune serum prevented attachment to trachea, 
Chick tracheal organ culture in serum free medium supported 
excellent growth of phase I B. pertussis while phase I bacteria would
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not grow in the serum free medium alone (lida & Ajiki, 1974), Fluores­
cent antibody techniques were used to visualise the bacteria adhering to 
the cilialêd epithelium. The localisation of the bacteria was strikingly 
similar to that seen in infected mouse brain or lung. Ciliary beating
g
ceased in the tracheal fragments when the viable count exceeded 10 in 
the tracheal fragment and surrounding medium. They also noted that the 
efficiency of bacterial attachment was low with increasing numbers of 
bacteria appearing in the medium, as organisms growing on the surface of 
the tracheal fragment were released, lida & Ajika (1974) concluded that 
the growth of B, pertussis was not dependent on growth factors excreted 
by the tissue fragments but required an unknown milieu intimately 
related to the tracheal fragment. In a later report lida & Ajiki (1975) 
showed that the oxidative phosphorylation uncoupler, 2,4-dinitrophenol, 
at levels non-toxic for B, pertussis or the ciliary motility of tracheal 
epithelium, inhibited bacterial growth on the organ culture. They 
postulated that the growth of B. pertussis on the tracheal organ culture 
depended upon a high energy-requiring process in the tracheal, fragments 
through which the physiological integrity of cells or fragments was 
maintained.
In 1977 two other groups of workers reported using tracheal 
organ cultures, rabbit trachea (Matsuyama, 1977) or hamster trachea 
(Collier et al, 1977; Muse e_t a_l, 1977), They found, as did lida & 
Ajika (1974), that phase I organisms attached to the surface of the 
ciliary epithelium. There are differences in the amount of damage 
caused by B, pertussis which may be accounted for by differences in 
methodology. The techniques used and results obtained in these 
studies are summarised in Table 1,
3) Modulation of B, pertussis
Modulation is defined as'a change of phenotype occurring in
14
TABLE 1 : Tracheal organ cultures infected with B, 
a comparison of methods and results
pertussis :
lida & Ajika 
(1974)
Collier ^  al (1977) 
Muse et al TT977)
Matsuyama
(1977)
Source of 
organ culture Chicken Hamster Rabbit
Medium 199; Earles & 
Eagles MEM
Equal parts SSM +
2x concentrated MEM
1.5 to 2% Agar 
in L “15 medium
Antibiotics 100 pg/ml strep­
tomycin (strep.)
Rings incubated with 
10 Upenicillin/ml 
before use
None
B. pertussis 
strains
phase 1: No 114
Tohama; 18323
or strep resistant
SM : 18323
phase III :
Tohama
phase 1 : 
Tohama; 35/2 
18323. 
phase III : 
Tohama, Sabairi 
& Sugata
Method of 
inoculation
Suspension with 
101.3 to lOr-3 
0.1 ml added 
to 1 ml of cul­
ture medium
B. pertussis grown 
in SSM to give O.D. 
of Ô.03. Rings 
immersed in 0.5 ml 
for 3 h at 37°C, 
washed
Point inocu­
lation with 
bacterial 
suspension 
(600 cfu)
Attachment
phenomena
Phase I ad­
hered to the 
surface of the 
ciliated epi­
thelium
Phase I adhered to 
the ciliated 
epithelial cells
Phase I adhered 
to ciliated epi 
thelium and wen 
resistant to 
clearance.
Phase III were 
cleared.
Cytopathic
effects
Disappearance 
of ciliary 
beating when 
viable count 
exceeded 10^ in 
each tracheal 
fragment 
culture
Loss of ciliary 
beating and gradual 
extrusion or 
destruction of 
ciliated epithelial 
cells
None
Abbreviations MEM - Minimum essential medium; SSM - Stainer & 
Scholte medium; O.D. - optical density
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all or almost all members of a population as the expression of a 
reversible and continuously environmentally dependent change in metabolism* 
(Lacey, I960), Modulation is quite different from the relatively 
stable and almost certainly mutational phase variation described by 
Leslie & Gardner (1931) and Lacey (1951, 1960). The three modes are 
called X-, C- and I-mode. I-mode will not be discussed here,
Envirnomental conditions determine the mode, high temperature (35° to 37°C) 
and ions (e.g. sodium, potassium and halides) favouring X-mode. C-mode 
is favoured by low temperatures (25°G), magnesium sulphate and mono- 
and dicarboxylic acids. The two modes are very different. C-mode 
cells, unlike X-mode, do not haemagglutinate (HA), are not haemolytic 
nor are they agglutinable by heavy metal salts. They lack the surface 
antigen common to B. parapertussis and B, bronchiseptica. The change 
from one mode to another occurs without mutation or selection and is 
complete within 7 to 15 cell divisions (Lacey, 1960), As well as 
modulation brought about by temperature and salts, X to C modulation can 
be induced by high nicotinic acid concentrations (Pusytai & Joo, 1967), 
and is accompanied by a fall in the levels of activity of protective 
antigen (PA) and histamine sensitising factor (HSF), Holt & Spasojevic 
(1968) showed that C-mode cultures had less protective activity than 
X-mode cultures when assayed by the i.c, mouse protection test,
Parton & Ward law ( 1974) and Ward law ^  aj^  (1976) showed that X- to C 
modulation is accompanied by loss of two envelope peptides as well as 
PA and HSF, Similarly, Parton & Durham (1978) showed loss of adenylate 
cyclase and Wardlaw e^ ^  (1979) loss of IgE adjuvanticity, Livey e_t 
al (1978) also reported the loss of heat-labile toxin in magnesium 
sulphate induced modulation,
4) Colonial variation
Andersen (1952), in the course of serial passage of strains
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of B. pertussis intracerebrally through mice, noted that in primary 
subcultures there were often marked differences in the size of colonies. 
Smaller colony variants tended to be more virulent, more toxic and more 
easily agglutinable than bacteria from large colonies. Colony size 
differences were lost on further subculture, but differences in viru­
lence, toxicity and agglutinability were retained even after numerous 
subcultures or freeze drying, Cameron (1976), after extensive studies 
on the colony variants found many different types of colony present in 
laboratory strains and in fresh isolates and noted variability in 
haemolytic activity and agglutinogens. Different colony types 
varied in the amounts of PA and HSF produced, and also in the ability to 
induce weight loss in mice. He did not suggest that any particular 
colonial or serological variant was associated with these properties 
except that the serotype 1 variants appeared to produce relatively 
little protective antigen and HSF and were considerably less toxic.
He, however, noted the possibilities of clone selection for high 
protective activity with low toxicity,
Co Pathophysiological properties 
associated with Bg pertussis
Bordet & Gengou (1907, 1909) and Bordet & Sleeswyck (1910) 
showed that freshly isolated strains were serologically similar but 
that many laboratory strains failed to agglutinate in the presence of 
antiserum prepared against freshly isolated strains, Bordet & Gengou 
(1909) also found that B, pertussis cells contained a heat-labile 
substance which, when given intraperitoneally or intravenously, killed 
guinea pigs and rabbits but when given subcutaneously produced necrosis 
of the skin. These early observations demonstrated two biological
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properties of B, pertussis, the agglutinogen and the heat-labile toxin.
Since then many other biological activities have been described which 
include many agglutinogen factors (Andersen, 1953; Eldering at al,
1957), a histamine-sensitising factor (Parfentjer & Good line, 1948), a 
heat-stable toxic lipopolysaccharide (Flosdorf & Kimball, 1940) and the haem- 
agglutinating (h A) substance (Keogh et al, 1947), Also^ as early as 1897, 
Frohlich noted a lymphocytosis reaction in many cases of whooping cough 
and work by Morse (1965) showed that this occurred when B, pertussis 
was injected into mice. The HA property of B, pertussis will be 
discussed in section
1) Heat-labile toxin (HLT)
The HLT is a cytoplasmic protein released upon cell lysis
and inactivated at 56°G within 15 min (Bordet & Gengou, 1909; Wood, 1940;
Munoz et al, 1959; Banerjea & Munoz, 1962), HLT causes a dermonecrotic
is
lesion when injected subcutaneous ly and/lethal for mice within 24 to 
48 h by intravenous or i.p, injection. When introduced i,n,, the 
toxin is approximately 100 times less active than by the other routes 
of injection (Anderson & North, 1943), Although the toxin is cytoplasmic 
it may appear in the culture supernate during the early exponential 
phase (Lane, 1968), Lane (1968) proposed that the cell surface blebs 
observed by electron microscopy (also reported by Morse & Morse, 1970) 
may have been the mechanism by which cytoplasmic elements were being 
released, Munoz & Bergman (1977) found HLT in the culture supernate of 
stationary phase rather than exponential phase cultures.
The methods of obtaining HLT involve disruption of cells 
under conditions which do not generate heat. Several groups of 
investigators have attempted to purify HLT with varying degrees of 
success (Robbins & Pillemer, 1950; Onoue nt al, 1963; Nakase £t al,
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1969; lida & Okonogi, 1971), Although HLT content of B. pertussis 
did not correlate with virulence (Standfast, 1951) it is suggested that 
the HLT must play some role in the pathogenesis of whooping cough 
(Munoz, 1971; Munoz & Bergman, 1977), since (i) in chick embryos the 
toxin produces lesions in the epithelial cells of the lungs (pall^van & 
Goodpasture, 1937), (ii) when given intracerebrally lesions are 
observed in the meninges of guinea pigs (Munoz & Bergman, 1977).
Standfast (1958) suggested that HLT produces ciliostasis 
which would represent a significant contribution to the overall patho­
genesis of the whooping cough syndrome since such an impairment of 
the host defence mechanisms would facilitate adhesion of the organisms 
to the ciliated epithelium, lida & Ajiki (1974), and Collier et al
(1977) when growing B, pertussis on organ cultures also noted ciliostasis. 
However in a later paper, (Muse e_t a_l, 1979) the possible role 
of a released pertussis toxin on host cell function was examined by 
immersing uninfected rings in culture filtrates and no effect on ciliary 
activity was noticed. They also reported that C mode cells induced 
ciliostasis at times similar to that induced by normal phase I organisms. 
Little if any HLT activity was detected in C-mode cells (Livey e_t al,
1978),
The reported absence of HLT antibodies in convalescent serum 
(Anderson & North, 1943; Evans, 1947) argues against an active role for 
HLT in the pertussis syndrome. Antitoxin is not protective against 
ioC, infections in mice (Verwey & Thiele, 1949) although this does not 
necessarily imply no protective role for antitoxin in i.n. infections. 
However Standfast (1951) found no correlation between HLT production and 
lethal i.n. virulence.
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2) Agglutinogens and serotypes of B, pertussis
The agglutinogens of B, pertussis are surface antigens which 
are easily extracted from the cell (Munoz, 1963). Also when cells are 
disrupted ultrasonically the agglutinogen is released almost entirely 
(Flosdorf et al, 1939), The substances are known only functionally 
and except for factor 1 which is protein (Onoue e_t al, 1961) little is 
known about their chemical nature. Nevertheless they are useful in 
classification and identification of B. pertussis strains.
Bordet & Sleeswyck(1910) described the agglutination of 
cells by B. pertussis specific antiserum and found all freshly isolated 
cultures agglutinated in the serum. For many years it was assumed that 
agglutination reflected the presence of a single agglutinogen. The 
complexity of the agglutinogen was not fully realised until Andersen 
(1953) and Eldering e_t a_l (1957) showed that smooth strains have a 
common heat-stable 0 antigen and one or more thermolabile surface 
antigens. Eight different agglutinogens have been reported for
B. pertussis (Eldering et al, 1962). Numbers 1 to 6 are species 
specific and numbers 7 and 13 are shared by other species of Bordetella, 
Agglutinogen 1 is common to all strains of B. pertussis whereas 2 to 6 are 
found in various combinations as strain specific antigens.
A relationship was found between antibodies to agglutinins 
in children and their resistance to whooping cough (Medical Research 
Council, 1959), but mice immunised with agglutinogen 1 were not 
protected against i.c. challenge (Schuchardt e_t al, 1963). Strains of 
different agglutinin types were found not to differ significantly in 
immunising efficiency or in lethality for mice immunised with factor 1 
strains. Using a passive transfer test, Eldering et al^  (1966) did not 
find any association between serotypes and mouse protection.
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3) Endotoxin (LPS)
Little attention has been given to the structure and 
function of B<> pertussis endotoxin when compared to those of entero- 
bacteria. Recent reports show the endotoxin extracted from Bo pertussis 
to possess a structure different from that of the enterobacteria (Le Dur 
et al) 1978; Ghaby al> 1979), The LPS is made up of two different 
polysaccharides of low molecular weight and two different lipids 
(Lipid X and Lipid A), The two polysaccharides are bound to lipid A, 
polysaccharide 1 through a single molecule of nonphosphorylated KDO and 
polysaccharide through a single molecule of phosphorylated KDO, The 
point of attachment of Lipid X is unknown. The LPS has all the usual 
biological activities of enterobacterial endotoxins. Lipid X is 
responsible for toxic, and pyrogenic properties caused by B. pertussis 
LPS and for the local Shwartzman reaction.
4) Pertussigen
The name "pertussigen" was proposed by Munoz (1976) to 
describe a factor with numerous properties isolated from B, pertussis. 
This reflected the inability to separate the lymphocytosis promoting 
factor (LPF) from the HSF and from other properties associated with 
these two activities. These include Islets Activating Protein (lAP) 
which causes hypoglycemia and an adjuvant activity for various classes 
of antibody including IgE, Pertussigen as defined by Munoz (1976) 
included the protective antigen (PA) which had not been separated from 
the HSF or LPF activities. Following the reported separation of PA 
and LPF activities (Arai & Sato, 1976), Pittman (1979) proposed the 
name pertussis toxin to include pertussigen activities other than the PA, 
However in this review the term pertussigen is used when the LPF, HSF,
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lAP complex is discussed. As most of the previous work done on 
pertussigen was described under the titles of LP^, HSF or more recently 
lAP activities, the pathophysiological reactions which led to their 
names will be described separately^ The evidence for these different 
activities being caused by a single component and evidence for and 
against it being a protective antigen will also be discussed.
(i) Lymphocytes is - B. pertussis stimulates lymphocytosis (a high 
level of lymphocytes in the blood)- in most patients over 6 months of 
age. The underlying mechanism was studied in detail by S.I. Morse and 
his colleagues.
The cells are for the most part normal, mature, small 
lymphocytes although a degree of polymorphonuclear leukocytosis may 
also occur. This effect occurred in mice when B« pertussis cells 
(Morse, 1965) or culture supernate (Morse & Bray, 1969)were inoculated 
intravenously, the lymphocytes reaching a maximum after 3 to 5 days and 
declining to a base line level in 2 to 3 weeks. With autoradiography 
Morse & Ries ter (1967) showed that the lymphocytosis was not caused by 
an increase in production of lymphocytes. but was primarily due to the 
entry into the circulation of mature cells from tissue pools. The 
accompanying polymorphonuclear leukocytosis was due to proliferation 
of myeloid elements and entry of mature cells from tissue reserves.
An impairment of the normal recirculation of lymphocytes was suggested 
as the reason for the maintained high level of lymphocytes in the blood, 
Athanassiades & Morse (1973) showed a pronounced decrease in the number 
of cells crossing capillary venules through which cells traverse to 
re-enter lymphoid tissue. Abnormality of lymphocytes exposed to LPF 
was shown by Morse & Ba^on (1970) who found that lymphocytes isolated 
from pertussis-treated mice, subsequently labelled with tritiated
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uridine and transferred into normal mice, entered the lymph nodes at 
a significantly lower level than did normal lymphocytes. Lymphocytes 
incubated in vitro with B. pertussis supernate or purified LPF showed 
the same effect (Iwasa et aj^ , 1970; Taub al,» 1972), Emigration 
is impaired probably by a change in the lymphocyte surface (Taub et al, 
1972), LPF combines with the surface of different cells types, 
including lymphocytes (Adler & Morse, 1973),
(ii) Histamine sensitization - This effect was first described by 
Parfentjer & Goodline (1948) who demonstrated that pertussis vaccinated 
mice became highly sensitive to the lethal effects of histamine where 
previously they were resistant. It was later found that these mice 
were more susceptible to serotonin, bradykinin, endotoxin and various 
other shock treatments (Munoz, 1963). The mechanism involved is not 
known but at the cellular level it is thought that HSF may either 
potentiate or inhibit the activity of regulatory substances. Support 
for this suggestion came from work by Bergman & Munoz (1966, 1971) who 
showed that adrenalin protects HSF-treated mice from lethal histamine 
challenge. The results of Fishel and co-workers (Fishel & Szentivanyi, 
1963; Fishel et al, 1962, 1968), strongly suggested an effect by
B, pertussis on adrenalin action. They also showed that p-adrenergic 
blocking agents can produce histamine-sensitivity in mice and that HSF 
blocks the hyperglycemic effect of adrenalin. However, Hewlett e_t a^
(1978) showed that B. pertussis does not cause p blockade and they 
propose that B, pertussis has an effect on insulin secretion,
(iii) Islets activation - Rats^ when given a single i.p. 
injection of pertussis vaccine, show enhanced hyperinsulinemia in 
response to insulin secretagogues such as glucose (Sumi & Hi, 1975), 
The active principle, a protein, was purified from culture supernate
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and was termed islets activating protein (lAP) (Yajima e_t al, 1978).
Ui (2t ^  (1979) proposed that lAP potentiated insulin secretion by inter­
acting directly but slowly with the pancreatic islet B cells causing 
sustained activation of native calcium ionophores in the\cell membrane.
This in turn, results in enhanced secretion by making more calcium 
available to the stimulus-secretion coupling mechanism,
(iv) Interrelationship between biological activities - Many attempts have 
been made to separate LPF and HSF activities (Lehrer ^  al, 1974, 1976;
Morse & Morse, 1976; Arai & Sato, 1976; Irons & MacLennan, 1979b) without 
success. One rather diffuse band is obtained in polyacrylamide gel 
electrophoresis (PAGE) of various 'pertussigen* preparations, when run in 
57o acrylamide at approximately pH 4,5 (Arai & Sato, 1976; Morse & Morse,
1976; Irons & MacLennan, 1979b; Ui et al, 1979), On boiling in sodium 
dodecyl sulphate (SDS) for 5 min and running in a higher acrylamide con­
centration (approximately 10%) four bands were obtained. The molecular 
weights of these bands are approximately 23,500, 19,300, 17,400 and 
13,400 (Morse & Morse, 1976), The chemical nature of the 'pertussigen* 
preparations differs between workers, Morse & Morse (1976) found their 
LPF preparation to be protein as did Ui e_t ^  (1979) who showed only 1 to 
1,5% carbohydrate and no detectable lipid in their LAP preparation..
However Arai & Sato found their preparation of LPF was only 47,7% protein 
with 25% carbohydrate and 23,9% lipid, Lehrer jet a^ (1974) also found a 
large percentage of lipid in their HSF preparation. All the preparations 
described LPF, HSF or lAP had activities other than that for which they 
were being purified, A HA activity was also associated with this complex 
(Arai & Sato, 1976; Irons & MacLennan, 1979a), The HA activity of 
pertussigen is distinct from the fimbrial haemagglutinin (F-HA) as it is
not sensitive to papain (Arai & Sato, 1976) nor is it inhibited by cholesterol,
(v) Pertussigen as a protective antigen - Much controversy exists over 
whether pertussigen is a protective antigen. Attempts to purify
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protective antigen resulted in fractions with pertussigen activities 
(Munoz & Hestikin, 1963; Robinson & Manchee, 1978), By the i.e. 
protection test, Sato e_t a]^  (1979) showed that formalised pertussigen 
(LPF) was not protective. Irons & Maclennan (1979a) showed that non­
formalised pertussigen was toxic at 4 pg per mouse when injected iop, and 
non-protective at lower doses. More recently Sato ejb ^  (1981) protected 
mice from aerosol challenge (Sato £t al, 1980) by injecting antiserum 
to pertussigen i.p, 30 min beforehand. In contrast to Sato e_t a_l
(1979), Munoz ejb al_ (1981) demonstrated that pertussigen, free of F-HA 
and detoxified by gluteraldehyde treatment actively protected mice 
against intracerebral challenge, Munoz ^  ^  (1981) also found that 
antiserum to pertussigen, given intraperitoneally 2 h before 
i.e. challenge, protected mice. If, as proposed by Pittman (1979), 
pertussigen acts as an exotoxin and is responsible, for the pathogenic 
effects of pertussis infection, then it would be expected thatan antibody 
to it would be protective. The difference in the results obtained by 
Sato ^  al_ (1979) and Munoz e_t al^  (1981) may be due to the method used 
to detoxify pertussigen.
D, Role of attachment in microbial ecology
1) General Background
Bacteria in many environments have a predeliction for 
colonising surfaces. As with colonisation of other surfaces^ organisms 
before they can colonise human and animal bodies must^first^become 
firmly attached and^second, they must be able to proliferate under the 
existing conditions. Specificity of attachment is proposed as a 
mechanism whereby the bacteria only become located on a surface suitable 
for proliferation and colonisation. The specificity of different
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bacteria for different surfaces in the nose and mouth were described 
(Gibbons ^  al, 1976; Aly e_t 1977), who showed the adhesion to 
different surfaces correlated with their natural site of infection.
The importance of the initial colonisation of mucosal 
surfaces is realised for a very varied selection of pathogenic microbes 
as Table 2 (adapted from Mitn-’s, 1977) illustrates.
Mechanisms of attachment may involve production of extra­
cellular polysaccharide, as for adhesion of lactobacilli (Brooker & 
Fuller, 1975) or filaments produced on the cell surface. Although 
Bo pertussis produces a capsule, there is no indication that this has 
a role in adhesion. Attachment may be mediated by fimbriae and for 
this reason further discussion is restricted to organisms with fimbriae- 
mediated adhesion.
The presence of fimbriae or filaments other than flagella 
were first observed in 1949 and 1950 (Anderson, 1949; Houwink & van 
Iterson, 1950), Anderson stated that the appendages he observed on the 
E. coli cell surface in the electron microscope were artifacts but 
Houwink proposed that they functioned as organs of attachment. Duguid 
et al (1955) agreed with Houwink & van Iterson that the filaments 
existed as appendages on living bacteria. In support of the proposed 
role in attachment, Duguid ^  ajl (1955) found that strains possessing
what he called fimbriae were distinguished by their ability to agglu­
tinate red blood cells,
2) Adhesion of pathogens to mucosal surfaces
(i) EnterobacteriaOMe. - Many of the Enterobacteriaceaeproduce type 1 
fimbriae as defined by Ottow (1975) but their role in adhesion has not
been clearly shown. Duguid & Gillies (1957) and Duguid e^ ^  (1966)
failed to show any relationship between the production of type I
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TABLE 2 : Microorganisms whose attachment has a role in pathogenicity
(adapted from Mimms, 1977)
Microorganism Disease Attachment
site
Mechanism
Influenza virus Influenza Respiratory
epithelial
cells
H.A. reacts 
with neura­
minic acid 
receptor on 
cell
Polio virus Poliomyelitis Susceptible 
tissue cell 
(neurone)
Viral capsid 
protein reacts 
with specific 
receptor on 
cell
Chlamydia Conjunctivitis Conjunctival
epithelium
Unknown-sialic 
acid receptor 
on epithelial 
cell
Mycoplasma
pneumonia
Atypical
pneumonia
Respiratory
epithelial
cells
'Foot* attache! 
to neuraminic 
acid receptor 
on cell
Neisseria
gonorrhoeas
Gonorrhoea Urethral
epithelium
Unknown
Vibrio
cholerae
Cholera Intestinal
epithelium
Unknown
Escherichia
coli
, Diarrhoea Intestinal
epithelium
Requires 
specific bact­
erial surface 
component eg 
K88
Streptococcus 
mutans
Dental caries Tooth Dextran ’glue' 
synthesised by 
bacteria
B. pertussis Whooping cough Respiratory
epithelium
Unknown
Plasmodium
knowlesi
Malaria Erythrocyte of 
susceptible 
host sp.
Unknown
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fimbriae and pathogenicity in the gut. However the role of other 
fimbriae-like adhesins found on the surface of enteropathogenic E, coli 
has been investigated. These other filaments are distinguished from 
type 1 fimbriae, which produce a mannose-sensitive HA by their mannose- 
resistant HA. The fibrillar K antigen of E. coli, K88, was shown to 
be produced vivo and to be responsible for the colonisation of 
pathogenic E. coli to the intestinal mucosa of neonatal piglets (Jones & 
Rutter, 1972), Bacteria without the antigen failed to adhere to the 
mucosa and hence failed to colonise and cause disease (Jones & Rutter,
1972), Also there is clear evidence that a similar mannose-resistant 
adhesin, K99, promotes intestinal infection in calves and lambs (Orskov 
et al, 1975; Burrows et al, 1976). Ninety-eight percent of entero­
toxigenic strains of E, coli from human adults also have a mannose-resistant 
HA either Colonization Factor 1 or 11, As the name suggests, these 
are also involved in colonization of the small intestine (Evans & Evans, 
1978; Evans e_t 1975; Evans e_t al, 1978), The role in pathogenesis
of diarrhoeal disease of CFA/1 was demonstrated in human volunteers
+  -given a virulent strain of E. coli which was either CFA or CFA . Only 
those given CFA^ strains contracted diarrhoea and showed prolonged 
excretion of bacteria,
Fimbriae-mediated adhesion also occurs in urinary tract 
infections (UTI) caused by E, coli. Here type 1 fimbriae may be 
involved, Svanborg-Eden & Hansson (1978) showed that 11 out of 12 
isolates from urine of UTI patients gave mannose-sensitive haemagglutin- 
ation of guinea pig erythrocytes. However it is not clear whether the 
fimbriae involved are of type 1 only as mannose did not inhibit the
II
adhesion of these strains to uroepithelial cells _in vitro, Kallenius
II
& Mollby (1979) proposed that adhesins other than type 1 fimbriae were 
involved. More recently Hagberg ejt aj^  (1981) indicated that the
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surface antigens of E, coli responsible for attachment to human urinary 
tract epithelial cells also induce mannose-resistant agglutination of 
human erythrocytes although many of these showed mannose-sensitive 
haemagglutination of guinea pig erythrocytes. This suggested that 
both type 1 fimbriae and a specific mannose-resistant adhesin were 
present on the cells,
(ii) Neisseria - Gonorrhoea is another disease where fimbriae are 
implicated in bacterial pathogenesis. This was first indicated when it 
was shown that there were four colony types of N. gonorrhoeae; the 
organisms from colony types 1 and 2 being virulent and fimbriate, 
colony types 3 and 4 being associated with avirulent and non-fimbriated 
organisms (Kellogg ^  1963; Swanson e_t al, 1971). Fimbriae
promote adhesion of vitro grown gonococci to cultured human amnion 
cells (Swanson, 1973), Many adhesion experiments are done using human 
buccal epithelial cells (Tramont, 1977; Lambden et al, 1979), Using 
human fallopian tube organ culture ( Wat4 ^  al, 1974)^which 
is highly relevant for the study of gonococcal adhesion, a four fold 
greater adhesion of fimbriated gonococci to the mucosal surface over a 
non-fimbriated variant of the same strain was shown (Watt & Ward, 1980). 
Fimbriate gonococci not only bind in greater numbers to human cells than 
do non-fimbriate cells but also they show an increased rate of attach­
ment, This may be critical in the transmission of the natural infection 
where flows of mucus or urine would tend to flush the bacterium from 
the mucosal surface (Watt & Ward, 1980), However as well as fimbriae 
outer membrane proteins play an important role in neisserial adhesion. 
Recently Virji & Everson (1981) using variants of N, gonorrhoeae strain 
P9 which differ in outer membrane proteins (Swanson, 1978; Lambden & 
Heck&^ l s , 1979), showed that one varient (P9-16) with no fimbriae but 
protein Ilb in the outer membrane had high avidity of attachment, for
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a Chang conjunctiva epithelial cell line. They also found that 
protein II increased the final level of adhesion compared to the proto­
type P9-1 which is non-fimbriate and lacking any protein II in the outer 
membrane. The rate of these non-fimbriate variants was however slow 
compared to a varient such as P9-20 which was fimbriate as well as 
containing protein II (Virji & Everson, 1981),
Lambden £t ^  (1980) showed that gonococci may possess what 
they term either cc or |3 fimbriae. They found that isolated a fimbriae 
attached to a greater extent to buccal epithelial cells than did (3 
fimbriae at pHs above 5 with maximum adhesion occurring at pH 6,5.
Both fimbriae types adhered to similar levels to erythrocytes. Virji 
& Everson (1981) with variants of P9, P9-2 which has a fimbriae and P9-20 
a p fimbriate variant,showed that the p-fimbriate variant attached to 
a higher level than did P9-2 to Chang epithelial cells. However P9-20^ 
the p fimbriate variant also contained protein II in the outer membrane 
which also increases the level of adhesion. These results indicate ■ 
the necessity of extending these attachment studies to other types of 
tissues so that the relative importance of the various components 
involved in attachment may be assessed under different circumstances of 
infection.
(iii) Vibrio cholerae - This organism differs from the two described 
previously in that it is not so restricted in habitat. Populations 
can be found in the human intestine as well as a variety of surface 
waters. Several adhesins may be synthesised by V. cholerae, the 
specificity and nature of which may depend on the habitat (Jones, 1980).
Haemagglutination by different strains of V. cholerae is 
inhibited by carbohydrates to different extents, some strains being 
inhibited by D-mannose (Barua & Mukherjee, 1965) whereas others are not
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(Jones & Fréter, 1976), Jones & Fréter (1976) found that the . H F \ - 
caused by classical V. cholerae cells grown In broth 
culture was Inhibited by L-fucose but not D-mannose while other workers
(Finkelstein e_t al, 1977 ) have described strains
s
producing insensitive to D-mannose and L-fucose.
These observations suggest that strains of V. cholerae produce several 
and it is not known which, if any, of those described 
is involved in colonization of the intestine (Jones, 1980). The 
nature of the HAs from V. cholerae is uncertain. V. cholerae
produces fimbriae and the more adhesive el tor strains are more fimbriate 
than classical cholerae vibrios and non-cholerae vibrios (Tweedy £t al, 
1968), However it is not certain that these fimbriae are the adhesive 
organelles responsible for the attachment of vibrios to brush border 
surfaces. Finkelstein et al (1977) have characterised a cell free 
haemagglutinin of a classical biotype of V. cholerae which has a very 
low M.W. (68,000) in the absence of depolymerising agents. Most 
adhesins described are long filaments of high M.W. but how this small 
HA is organized on the bacterial cell surface is unknown.
There is evidence that this HA is involved in adhesion as
it inhibits the attachment of an el tor vibrio strain to intestinal 
epithelium of infant rabbits (Finkelstein et al, 1977). All work on 
V. cholerae adhesion to intestinal epithelial cells is complicated by 
the fact that colonisation is dependent on three stages - a) organisms 
detect and move towards the mucosa by following gradients of chemo- 
attractants (Allweiss _al, 1977), b) organisms then penetrate into 
and through the mucus gel (Freter et al, 197 8) and finally c) the 
organisms.adhere to the brush border surface of the epithelial cells 
(Nelson et al, 1976). Interference with any of these steps may disrupt 
the process of association (Freter e^ aJ, 1978).
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The three groups of organisms discussed were chosen to 
illustrate the complexity of bacterial adherence to epithelial 
surfaces. The overall mechanisms involved require further elucidation 
before reliable anti-adhesive vaccines can be produced.
3) Interaction of bacteria with animal cell surfaces
Both bacterial and mammalian cells have a net negative charge, 
Bacterial adhesion to animal cells illustrates an apparent paradox 
where two bodies of the same surface charge can attract and adhere to
one another. This can be explained in part by application of the
DLVO theory (Derjaguin & Landau, 1941; Verwey & Overbeek, 1948). This 
theory considers that the energy of interaction of two charged particles 
of like sign and magnitude is the resultant of the electrostatic 
energy of repulsion and the energy of attraction provided by London-van
der Waals forces. The forces of repulsion and attraction between
approaching surfaces vary with the distance of separation in such a 
manner that the surfaces at two distances attract one another. One 
energy level that favours surface-surface interaction occurs at the 
close approach of the particles and is known as'the primary minimum.
A  further attraction occurs at the secondary minimum which involves 
greater distances of separation. The secondary minimum (Curtis, 1973) 
occurs at a separation distance determined by the nature and ionic 
environment of the contacting surfaces. In an electron microscope 
study Ward & Watt (1975) estimated a separation between the gonococcus 
envelope and the mucosal surface of a fallopian tube organ culture of 
13 nm, a distance suggesting adhesion at the secondary minimum. In 
the interaction of the gonococcus with the mammalian cell surface the 
DLVO theory alone cannot explain the adhesion as there is a specificity 
of attachment indicated by the ability of the gonococcus to adhere to
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and invade the moving surface of the human fallopian tube but not the 
rabbit oviduct (Taylor-Robinson et al, 1974). However secondary 
minimum adhesion may be a preliminary stage in gonococcal attachment 
permitting subsequent, specific primary adhesion. The importance of 
surface charge on gonococcal adhesion was illustrated by Heckles £t ^  
(1976) who showed that neutralising the negative charge of the gono­
coccal surface increased the adhesion of fimbriate gonococci and that 
of non-fimbriate bacteria to a similar level.
Gonococcal fimbriae appear to reduce the forces of 
repulsion between the bacterial and mammalian cell surface since 
fimbriated cells adhered to a greater extent than non-fimbriated ones.
It is possible that by their hydrophobic nature and small diameter they 
allow the organisms to come close enough to the epithelial cells to 
allow secondary minimal adhesion.
(i) Hydrophobic interactions - There is a preponderance of non-polar 
side chains in the amino acids of type 1 fimbriae, K88 fimbriae of 
E^coli and gonococcus fimbriae (Jones, 1977; Watt & Ward, 1980). Smyth
et al (1978) showed that K88 antigen were solely responsible for the 
binding of smooth -enteropathogenic E. coli to octyl and phenyl-Sepharose 
gels, K88 -ve strains showing no adsorption to hydrophobic columns.
Smyth e^ al^  (1978) suggested that there is a role for hydrophobic inter­
action in fimbriae mediated adhesion in E. coli. They suggest that 
reduction in the surface potential due to the masking of the charge 
contribution of polysaccharide K antigens and lipopolysaccharide by 
certain fimbriae with hydrophobic characteristics probably promotes 
adhesion.
Although gonococcus fimbriae avidly adhere to octyl or 
phenyl sepharose, fimbriated gonococci were only approximately 20% more
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efficient at binding to hydrophobic sepharoses than non-fimbriate cells. 
The outer membrane proteins of gonococcus play a part in hydrophobic 
binding, as variants with different outer membrane proteins differ in 
adhesion to phenyl sepharose (Watt & Ward, 1980),
E. The HA*s of B. pertussis
In 1947 Keogh eJt observed that erythrocytes of man, fowl 
and other animals were agglutinated by saline suspensions of B. pertussis 
and also by filtrates and supernatant fluids of liquid cultures. The 
degree of cell-association and time of maximum release of the HA into 
the culture medium was dependent on the size of the inoculum and the 
suitability of the medium. Keogh & North (1948) found that strains of 
B. pertussis with maximum HA content showed maximal virulence. In 
contrast Standfast (1951) found no correlation between virulence and 
viable count, presence of toxin or HA, Keogh & North also showed that 
the supernates from liquid cultures of B. pertussis with 'adequate' HA 
content protected mice against i,n. infection as efficiently as did
vaccines prepared from B-G cultures. Following these early reports
suggesting a protective role for HA, Masry (1952) found no protective 
activity with an isolated HA preparation as immunogen. After an 
interval of almost 20 years further work on the HA of B, pertussis 
began in the 1970s when the role of adhesins in pathogenicity of 
several organisms became clear.
1) Growth of B. pertussis and associated HA activity ijn vitro
(i) Solid Medium - There does not seem to be any correlation between 
incubation time and the HA content of B. pertussis grown on solid medium. 
Ungar (1949) stated that cultures grown for 24 or 48 h on B-G showed
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HA whereas those grown for 72 h had very low HA activity, Masry (1952) 
obtained no such variation with B-G cultures and reported no difference 
in the HA titre of cell suspensions from 24, 48, 72 or 96 h cultures.
(ii) Liquid Medium - Liquid medium is convenient for direct comparison 
between growth and production of HA in different strains. Shallow 
layers of static liquid culture were most commonly used for production 
of HA. According to recent reports where growth and HA production in 
both static and shake cultures is compared, static culture favours the 
production of fimbrial-like protrusions on the cell surface (Irons & 
MacLennan, 1979a; Arai & Munoz, 1979b).
Fisher (1948) showed that neither the rate of multiplication
nor the final yield of B. pertussis was influenced by the size of the
inoculum and the final yield of organisms in different cultures was
9 -1
between 10 and 20 x 10 ml . Similar maximum counts were obtained 
by other workers (Keogh & North, 1948; Masry, 1952; Morse & Morse,
1970; Sato et al, 1974). Fisher (1948) showed that the HA content of 
the cells fell with the increase in total count and the HA titre of 
supernates and then declined. The rise coincided with the
rise in pH, the decrease reflecting destruction of the HA, Masry (1952) 
and Sutherland & Wilkinson (1961) obtained similar results. However 
other workers did not obtain the same HA patterns with growth. Keogh 
& North (1948) showed an increase in both cell and supernate HA activity 
with growth whereas Sato e_t al^  (1974) observed an increase in cellular 
HA activity which started to decrease as the cells moved into stationary 
phase. The HA titres of the supernate ran almost parallel with that 
of the cells. Differences in medium and in the HA assay systems may 
account for conflicting results. Arai & Munoz (1979b) compared the 
growth and HA production of two strains of B. pertussis in two different 
media (Sato et al, 1974; Munoz et al, 1978). Very little or no HA
35
was detectable with either strain in either medium when in shaken 
culture. However in stationary culture high HA titres were obtained 
with both strains in the medium used by Sato et ^  (1974) but not in 
that used by Munoz ^  8^ (1978), In the Sato medium Arai & Munoz 
(1979b) found that the HA activity associated with both the cells and 
supernate increased during logarithmic growth of the organisms.
In an ultrastructural study Morse & Morse (1970) followed 
changes in the appearance of B. pertussis when grown in static liquid 
medium. During the first 48 h round particles of heterogeneous size, 
a small number of filaments, and long dumbe11-shaped particles appeared 
in the culture supernate. Larger numbers of filaments were seen 
attached to the cell surface after 48 h culture but after 4 days 
virtually no cell associated filaments were observed. The early 
appearance of these filaments on the cell and then later in the super­
nate follows the pattern of haemagglutination associated with the 
bacterial cells and with the sypernate described previously by Fisher 
(1948). The appearance of similar filaments on the cells and in the 
supernate were observed by Sato ^  ^  (1974). However, they observed 
filaments on both the cells and in the supernate during logarithmic 
growth of the cultures.
2) Purification of the HA
The first attempt to elute HA from cells of B. pertussis was 
made by Warburton & Fisher (1951), using IM NaCl at pH 8.5. The cell 
free HA was then precipitated with IM NaCl and adsorbed onto Al PO^, 
pH 5.5, this being used to immunize mice. Protective activity was 
shown after the mice were challenged with a lethal intranasal dose of 
Bo pertussis. The significance of this result was unclear since the
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HA preparation also contained agglutinogen. A further attempt at 
purification of HA was made by Masry (1952) who extracted HA from cells 
grown for 24 h on B-G medium with 2M NaCl or with IM sodium acetate 
followed by methanol precipitation. The NaCl extract contained 
agglutinogen whereas none was detected in the methanol precipitated 
sodium acetate extract. Both extracts were toxic, though differing in 
potency, producing necrotic lesions similar to those described by Evans 
& Maitland (1937) for the thermolabile toxin. In protection tests the 
methanol precipitate was adsorbed onto fowl red blood cells before i.p, 
injection into mice. This vaccine showed little or no protective 
activity against an i.e. challenge with 200 LD50*s of B, pertussis cells.
Following these early efforts at purification of HA no 
further attempt was made until that of Sato & Arai (1972) who noted 
filamentous structures in partially purified LPF. The preparation had 
a high histamine sensitising activity as well as high HA activity.
Later Sato eJt al^  (1974) reported that the partially purified LPF was 
protective against i.c, challenge, Nakase e^ al^  (1975) described a 
purification procedure which yielded HA free from histamine sensitising 
activity, lymphocytosis promoting activity, heat labile toxin, K and 0 
agglutinogens and had no protective activity. Both the HSF and LPF 
were isolated and recovered in other fractions.
Morse & Morse (1976) separated HA and LPF, the HA preparation 
having no lymphocytosis promoting activity and being mainly filaments.
The LPF preparation had minimal HA activity and consisted of round 
particles. At about the same time, Arai & Sato (19.76) reported a rapid 
decrease in HA activity after treatment with papain, whereas lymphocytosis 
promoting activity was much less sensitive to this enzyme. Fractionation 
of the LPF preparation (Sato & Arai, 1972) on 6% sepharose yielded two 
fractions, one being filaments the other spherical particles. The
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filaments were free of lymphocytosis promoting activity and contained 
most of the papain sensitive HA. LPF was associated with the 
spherical particles which possessed papain resistant HA activity.
More recently Arai & Munoz (1979a) and Irons & MacLennan (1979a) 
described purification procedures. Arai & Munoz (1979a) used ion 
exchange chromatography followed by fractionation on 67. sepharose,
Irons & MacLennan (1979a) ammonium sulphate precipitated culture 
supernate, the precipitate was then extracted with 50 mM Tris/HCl buffer 
with IM NaCl pH 8.0. The F-HA was adsorbed from the extract by being 
adsorbed onto cholesterol containing liposomes. A summary of 
purification procedures for F-HA is summarised in Table 3,
3) Properties of the HAs
Cells of B. pertussis agglutinate many different types of 
red cells (Ungar, 1949) with no evidence of species specificity. The 
HA is antigenic and although 977. of HA activity of whole cells or the 
purified filaments responsible for haemagglutination was destroyed at 
56°C, a large proportion of antigenic potency remained (Fisher, 1950).
The properties described in this section are those associated with the 
purified F-HA. Properties of the pertussigen HA are described in 
section C4.
Electron microscopy showed the F-HA to consist of homogeneous 
filaments (fimbriae) about 2 nm in diameter and about 40 nm in length 
(Nakase et al, 1975; Arai & Sato, 1976; Morse & Morse, 1976; Irons & 
MacLennan, 1979a). The fimbriae were insoluble in water but disaggregated 
in high salt or alkaline solvents pH 10 to 11 (Nakase e_t aj^ , 1975;
Arai & Sato, 1976), The molecular weight of the disaggregated filaments, 
determined by gel filtration was approximately 70,000 (Nakase e^ 1975). 
In SDS-PAGE of the F-HA, Arai & Sato (1976) obtained a major band
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corresponding to a molecular weight of 126,000 and several minor bands 
from 120,000 to 52,000 which were thought to be degraded products.
Irons & Maclennan (1979a) obtained similar gel patterns with two major 
bands at 127,000 and 95,000 and several minor bands. Chemical analyses 
of the F-HA by Nakase e_t ad (1975) and Arai & Sato (1976) yielded very 
similar results with about 85% protein, 5% carbohydrate and 4% lipid. 
However Arai & Munoz (1979) found their F-HA preparation to be at least 
97% protein,
F, Attachment of B, pertussis
lo Requirement for attachment
Air contains a variety of suspended particles including 
microorganisms. Efficient cleansing mechanisms in the lungs remove 
inhaled particles and keep the respiratory tract clean.
A mucociliary blanket covers most of the surface of the 
lower respiratory tract. It consists of ciliated cells together with 
mucus secreting cells (goblet cells) and subepithelial mucus secreting 
glands. Foreign particles deposited on this surface are entrapped in 
mucus and borne upwards from the lungs by ciliary action to the back of 
the throat before being swallowed. The upper respiratory tract has a 
similar clearing system. The terminal portions of the lower respiratory 
tract are the alveoli which have no cilia or mucus but are lined by 
macrophages,
For a microorganism to initiate infection in the respiratory 
tract it must circumvent the mucociliary clearance mechanism and if it 
reaches the alveoli it must resist phagocytosis by alveolar macrophage 
or if phagocytosed, must survive and multiply rather than be killed and 
digested. Microorganisms have little chance unless the mucociliary
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mechanisms are defective or unless they have, a special device for 
attaching firmly to epithelial cells. An example of this is seen with 
influenza virus, which has a surface HA which reacts specifically with 
sialic acids on epithelial cells (Hirst, 1965), A firm union is 
established and the virus infects cells. As B. pertussis infects the 
lower respiratory tract it is proposed that some similar mechanism 
involving attachment to the epithelial layer contributes to the ability 
of the organism to infect a normal lung,
2, Site of attachment
B, pertussis is found localised on the ciliated epithelium 
of the respiratory tract, Arnheim (1903) and Mallory and Horner (1912) 
showed that in cases of pertussis, bacteria were found mainly among the 
bronchial and tracheal cilia, Gallavan and Goodpasture (1937) showed 
that, in chick embryo infected with B. pertussis, the organisms grew 
among the cilia of the respiratory tract and of the transiently 
ciliated pharynx and oesophagus. The specificity of the organisms for 
the ciliated cells is illustrated in scanning electron microscope 
pictures of organisms attached to the ciliated cells in tracheal organ 
culture (Muse £t al, 1977). In i.c. infections of mice it has been 
shown that the organisms again attach specifically to the ciliated 
ependymal cells (Hopewell et al, 1972), Berenbaum et al (1960) showed 
that bacterial multiplication in the mouse brain was limited to the 
cranial cavity in which it was practically confined to the ciliated 
layer over the ependyma. Whether the sites of adhesion are on the cilia 
themselves or the microvilli of the ciliated cells is unclear. In the 
mouse brain infections (Hopewell ^  al, 1972) bacteria appeared to be 
held between microvilli of ependymal cells and no evidence was obtained 
for bacterial attachment to cilia. Muse e_t (1977) showed by
41
scanning electron microscopy the apparent attachment of organisms to 
cilia of tracheal organ cultures infected with B. pertussis.
3. Proposed mechanism of attachment
The identity of filamentous HA with the filamentous 
appendages on the cell surface was shown by the uniform attachment of 
the specific HA antibody molecules to the bacterial fimbriae
(Sato et al, 1979). Avirulent phase III organisms lacked fimbriae and 
did not attach to HeLa cells (Sato e_t al, 1979) or to rabbit tracheal 
organ cultures (Matsuyama, 1977). Antibody to phase III organisms did 
not prevent phase I bacteria adhering to HeLa cells whereas homologous 
phase I antibody or antibody to isolated HA largely prevented attachment 
(Sato ^  1979). The weight of evidence suggests that fimbriae play
a part in pathogenesis of B. pertussis by being involved in attachment 
of the organism. Whether or not the HA property of the pertussigen 
component (Arai & Sato, 1976; Irons & MacLennan, 1979a) reflects a 
role in adhesion ijn vivo is not known. Also the possibility of other 
outer membrane proteins being involved in adhesion cannot be ruled out,
4. Cell surface receptors for the HAs of B. pertussis
The most common receptors suggested for bacterial adhesins 
on cell surfaces are carbohydrate such as a-D-mannose which inhibits 
the HA of common type I fimbriae from the Enterobacteriaceae
(Duguid e_t a_l, 1966; Tweedy et al, 1968; Old, 1972). The evidence 
for manno se being the receptor vivo is less clear. Schaeffer e_t al 
(1979) reported the adhesion of E. coli, isolated from urine, to uro­
epithelial cells as being completely inhibited by a-D-mannose, However 
in an earlier report Svanborg-Eden & Hansson (1978), again using strains 
of E. coli isolated from urine, found no inhibition of the adhesion of
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these strains to uroepithelial cells by D-mannose. For some strains 
of Vo cholerae both the adhesion to brush-border membranes and HA are 
inhibited by L-fucose (Jones & Freter, 1976). The HA of turkey 
erythrocytes by Mycoplasma gallisepticum does not occur if the erythro­
cytes are pretreated with neuraminidase (Gesner & Thomas, 1965), 
implicating sialic acid residues in the receptor complex.
Pertussigen induced HA is inhibited by the sialoproteins 
haptoglobin and ceruloplasmin type III, Removal of the sialic acid 
residues from the proteins by pretreatment with neuraminidase reduced 
their inhibitory effects to less than 1% of its former value indicating 
sialic acid as the receptor (Irons & MacLennan, 1979a). As isolated 
sialic acid did not inhibit the HA by pertussigen (Irons & MacLennan, 
1979a) the receptor is probably more complex requiring a specific 
orientation of the sialic acid residues.
Sato £t al^  (1979) and Irons & Maclennan (1979a) showed that 
F-HA activity was inhibited by sterol containing liposomes, Sato 
et al (1979) demonstrated inhibition of F-HA by cholesterol, concluding 
that the fimbrial receptor involved cell membrane sterols with a cis- 
hydroxyl at the C3 position. In a comparative study of the effects of 
sterol structure on F-HA inhibiting activity Irons & MacLennan (1979a) 
used a liposome system to show that only those containing cholesterol, 
dihydrocholesterol or p-sitosterol as the sterol moiety were effective 
in binding fimbriae from cell extracts, stigmasterol and epicoprostanol 
being ineffective. Binding of fimbriae was confirmed using SDS-PAGE to 
demonstrate the presence of two proteins with molecular weights of 
127,000 and 95,000 on the liposomes.
Whether or not the sialoproteins and sterols, proposed 
receptors for the two haemagglutinins of B. pertussis, have a role 
in vivo has not been investigated,
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Go Protection against B. pertussis infection
lo Protective antigen
Of great interest is the nature of the antigen(s) that 
protects mice against i.Co challenge. The laboratory assay for i.e. 
protection has proved to be the most reliable indicator of the protective 
value of whooping cough vaccines in man (Standfast & Dolby, 1961). 
Standfast (1958) showed that the lethal ion* protective factor was 
different from the i.c* factor, but Andersen & Bentzon (1958) found the 
protective potency of vaccines as assayed using a sublethal i.no challenge 
were similar to i.e. protective potencies.
Many attempts have been made to purify the protective antigen 
with only partial success (Billaudelle ^  al, 1960; Barta, 1963; Munoz 
& Hestikin, 1963; Sato & Nagase, 1967; Robinson & Manchee, 1978).
Pittman (1979) proposed a protective role for the F-HA, and suggested 
that pertussigen is an exotoxic, factor, responsible for many of the 
disease symptoms of whooping cough, and therefore antibodies against 
pertussigen will also be protective. Controversy exists as to whether 
pertussigen is a protective antigen and whether or not another non-toxic 
protective antigen exists. Pertussigen (as indicated by the presence of 
one of its activities) and PA have been shown to be present in similar 
quantities in different strains of B. pertussis and in more purified 
fractions (Pittman, 1951; Maitland £t 1955; Munoz & Hestikin, 1963; 
Pieroni e_t al, 1965) but several observations indicate they are not 
identical. Though HSF activity may parallel that of PA (Joo & Pusytai, 
1960) the response of mice to pertussigen as measured by histamine 
sensitisation and protection against i.e.- challenge is distinguishable 
(Fishel, 1956). Nagel (1967) claimed separation of the two active 
components.
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There are reports which claim protective activity associated 
with purified pertussigen preparations (Munoz e^ al, 1981; Sato al,
1981) and also with F-HA preparations (Sato £t 1979; Irons &
MacLennan, 1979a). These reports Indicate that there is not one PA but 
at least two proteins which can protect against B. pertussis infections 
in mice.
Pertussigen as a potential protective factor has been 
discussed earlier. In the following sections (a) the stimulation of a 
local immune response possibly an antiadhesion response, and (b) antiadhesion 
or anti F-HA as a potential protective factor will be discussed.
2. Local immune response induced by B. pertussis
Cheers and Gray suggest a role for cellular immunity in the 
recovery of mice from lung infections (Cheers,' 1969; Cheers & Gray, 1969; 
Gray & Cheers, 1967; Gray & Cheers, 1969). They found an initial rapid 
multiplication of organisms followed by a decline in viable organisms to 
about 1% of this level after invasion by phagocytic granulocytes. At 
this stage bacteria were found within alveolar macrophages. Many of the 
bacteria survived within the phagocytes with the net result that steady 
state was reached and the number of viable organisms neither increased 
nor decreased (complaisant phase). To eradicate all the organisms, a 
protective humoral response was necessary and it would seem that the 
final cure and subsequent immunity was associated with a humoral response.
The role of local immunity, secretory IgA and IgG, in the 
mucous membrane seems to be important. Holt (1972) suggested a locally 
produced IgA response prevented the adhesion of organisms to the raucous 
membrane, this being the type of immunity the infection itself induces 
whereas parenteral vaccination Induced a separate type of immunity, 
involving polymorphonuclear leukocytes and an opsin. Geller & Pittman
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(1973) followed the production of different classes of antibody in serum 
and nasal secretions during the course of a sublethal ion. infection in 
mice. Bo pertussis specific IgG and IgA (but no IgM) appeared in 
respiratory tract secretions by day 15 and increased with time, IgA was 
the most abundant antibody present. In serum the most significant 
observation was the rise in serum IgA in i.n. infected mice after 30 days. 
However their study does not clarify how parenterally administered 
pertussis vaccine prevents the development of whooping cough. They 
propose that trace amounts of immunoglobulins in respiratory tract 
secretions of some intraperitoneally vaccinated mice suggest that serum 
immunoglobulins may pass the lung barrier. In a recent report using an 
enzyme-linked immunosorbent assay (Goodman ^  1981) antipertussis IgA
was detected in secretions during natural human infection usually appearing 
during week 2 or 3 of illness. . It was most frequently found in patients 
from whom the organisms could no longer be recovered.
IgA l$i important in protection against other pathogens.
Adinolfi ^  ^  (1966) found that antibody to E. coli in colostrum was 
mainly IgA. The serum and cervicovaginal secretions of women with 
gonococcal cervitis contained IgA antibodies to N. gonorrhoeae (O'Reilly 
et al, 1976). Secretory IgA and IgG prevented adhesion of E. coli to 
human urinary tract epithelial cells (Svanborg-Eden & Svennerholm, 1978).
In studies with V. cholerae^protection by secretory IgA was associated 
with decreased bacterial attachment to intestinal mucosa (Fubara & Freter, 
1973) and saliva containing IgA reduced the adhesion of streptococci to 
the lining of the oral cavity (Williams & Gibbons, 1972).
Parenterally administered vaccines can elicit a secretory 
response but the levels of local antibody are usually low and a much more 
pronounced antigenic stimulus can be achieved by direct application of a 
vaccine on the mucosal surface (Perkins e_t al, 1969). This was' illustrated
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in pertussis infections by North & Anderson (1942) who showed that i.n. 
vaccination of mice gave better immunity to i.n. infection than i.p. or 
subcutaneous vaccination.
3. Role of fimbriae or HA's in protection
In infections where fimbriae or fimbriae-like appendages have 
a role in the pathogenesis, a degree of protection has been elicited with 
fimbrial vaccines (Buchanan et al, 1977; Brinton et al, 1978). Fimbriae 
vaccines of N. gonorrhoea have induced some protection, although the anti­
body response was only weakly bactericidal. The maximum inhibition of 
attachment occurred when the antibodies were directed against fimbriae 
antigenically identical to the fimbriae mediating the attachment 
(Buchanan eib al, 1977; Brinton ^  al, 1978). With E. coli intestinal 
infections of animals, purified fimbriae have been used as successful 
vaccines. Jones & Rutter (1974) and Rutter e_t al (1976) showed that 
piglets suckled by dams vaccinated into the mammary glands with purified 
K88 fimbriae were significantly more resistant to lethal neonatal diarrhoea 
after challenge with K88-positive enteropathogenic E. coli. Similar 
work using colostral transfer of antibodies induced by purified fimbriae 
to protect against E. coli infection has been done with K99 and 987 
fimbriae in calves (Sojka e_t al, 1978; Nagy e_t a^, 1978; Morgan £t al, 
1978).
With B. pertussis, Keogh & North (1948) found that protective 
potency of sera given i.p. against i.n. infection was directly related to 
their anti-HA titres. Masry (1952) using a more highly purified 
preparation of HA absorbed to chicken erythrocytes as vaccine found little 
or no protection against i.e. infection when compared with a control 
whole cell vaccine. Pillemer (1950) prepared an antigen,- absorbed onto
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red blood cell stromata, from B. pertussis which was protective but not 
identical with the HA although it was later shown to have histamine 
sensitising activity (Pillemer ^  al^ , 1954). Sato (1974) showed that 
red cell stromata added to a sonic extract of strain 134 by Pillemer*s 
method (1950) absorbed LPF, HSF and HA activities suggesting that 
Pillemer'5 stromata-absorbed protective antigen was formed by adsorption 
of these factors onto the stromata. Sato ^  aj^  (1974) with a formalin 
treated preparation of pertussigen and F-HA showed both active and
passive protection in mice against i.e. challenge. In 1976 Arai & Sato
separated the two components, and subsequently showed that the protection 
against i.e. challenge was associated with the F-HA (Sato £t al, 1979). 
Sato e_t a_l (1979) also showed that anti F-HA antibodies prevented
attachment of B. pertussis to HeLa cells. Munoz ^  a_l (1981) found no
protective activity against i.e. challenge with their preparation of F-HA 
which was free of detectable pertussigen activity. However their 
pertussigen preparation was protective. Sato e_t ad (1981) showed passive 
protection in mice against a sublethal i.n. challenge with both antiserum 
to pertussigen and to the F-HA. Further work is required to determine 
whether or not the F-HA is a protective antigen, and the effects of 
purification methods on protective properties. If the F-HA is protective 
it is likely to act by preventing adhesion and therefore colonization of 
B. pertussis in the respiratory tract. To inhibit adhesion at the 
mucosal surface an antibody response at the lung surfaces would be 
required.
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OBJECTS OF RESEARCH
It is generally accepted that an important early event in 
B. pertussis infection of the mammalian respiratory tract is the 
adhesion of the bacteria to the ciliated epithelium. However the 
bacterial components involved in this adhesion have not been identified 
with certainty, although the F-HA is believed to play a role.
The primary object of this investigation was to explore 
this possibility by (a) studying the involvement of the F-HA in 
B, pertussis adhesion and virulence,
(b) testing the ability of a purified F-HA vaccine 
to protect mice against B. pertussis infection given by the i.n. and
i.e. routes,
and (c) examining the effect of an F-HA inhibitor on 
the adhesion and virulence of the organism.
A second objective was to compare the hydrophobicity of 
virulent and avirulent B. pertussis, and also fimbriated and non­
fimbriated virulent cells, to determine possible correlations.
Before investigating the above, it was necessary to study 
the influence of cultuxal conditions on the production of F-HA so as 
to obtain B. pertussis cells with different amounts of this component.
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MATERIALS AND METHODS
A» Growth and cultivation
lo Strains .
Several freshly isolated strains of B. pertussis were used 
viz: 77/18319, 77/19110, 77/35296, 77/25171 all supplied as fresh 
isolates from cases of pertussis by Dr. R. Fallon (Ruchill Hospital, 
Glasgow). Strain 18323 was the mouse virulent strain used in the 
mouse protection test (Kendrick ^  al, 1947) and was supplied by Dr, F. 
Sheffield (National Institute for Biological Standardisation, London), 
Strain Taberman, an isolate from postmortem material was supplied by 
Prof. G.T, Stewart (Ruchill Hospital, Glasgow). Strains D30042 phase I 
and D30042 phase IV were obtained from Dr. J, Dolby (Clinical Research 
Centre, Harrow, London), and strains 44122/7S and 44122/7R were from 
Dr. P. Branefors (Dept, of Bacteriology, University of Goteborg, 
Goteborg, Sweden), Strain 44122/7 transformant X was supplied by Mr, 
Salah al Salami of the Dept, of Microbiology, University of Glasgow, 
Intracerebrally, strain 44122/7S was avirulent whereas strains 44122/7R 
and 44122/7 transformant X were virulent.
2, Media
Bordet-Gengou (B-G) medium (Gibco Biocult Ltd) supplemented 
with 20% (v/v) horse blood (Gibco Biocult). The liquid media were 
(i) X mode "Hornibrook's medium", a modification of that described by 
H^rnibrook (1939) as used by Wardlaw al_ (1976), (ii) a modification
of Hornibrook (1939) as used by Sato e_t ^  (1974), Both these media 
were used to grow X mode cells; C mode cells (Lacey, 1960) were grown 
by replacing the NaCl with an equal amount of MgSO^. The compositions 
of the media are in Appendix I.
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3o Growth and storage
Freeze dried organisms were reconstituted from ampoules and 
plated onto B-G agar plates. After about five days incubation at 35°C 
in plastic boxes, the resultant confluent growth was resuspended in a 
1% (w/v) casamino acids (Difco) diluent (CAD) pH 7 (Appendix 2) con­
taining 107. (v/v) glycerol and stored as a cell suspension at -70°C.
These cell suspensions were used for subsequent inoculations of B-G 
plates when required.
Inocula for flasks of liquid media were prepared by resus- 
pending the growth from 24 h B-G plates in a small volume of the liquid 
medium. Static cultures were grown in shallow layers of medium in 
Roux bottles (100 ml) or in Erlenmeyer flasks (400 ml of medium per 2 litre 
flask, 50 ml per 250 ml flask). The flasks were incubated at 35^C for 
4 to 5 days without shaking. Shake cultures were grown using similar
volumes to static cultures but in dimpled Erlenmeyer flasks at 35°C on an
— 1
orbital shaker at 100 cycles mih for up to 72 h. Liquid cultures were 
harvested by centrifuging at 10,000 g for 30 min at 4°C, and the pellet 
resuspended in either CAD or CAD plus 10% (v/v) glycerol when low 
temperature storage was required.
4. Standardisation of bacterial suspensions
Bacteria for infection experiments and adhesion assays were 
resuspended in CAD to 10 opacity units (ou), the same opacity (as judged 
by eye) as the International Opacity Standard (W.H.O. International Lab, 
for Biol. Standards, Nat. Inst, for Biological Standardisation and 
Control, Holly Hill, Hampstead, London). Suspensions of 10 ou are 
equivalent approximately to a total count of 10^^ bacteria ml ^.
Suspensions were further diluted depending on the number of viable
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organisms required. For some HA assays more dense bacterial suspensions 
were used which were standardised by diluting a sample to 10 ou and 
correcting the original suspension to a standard number of ou,
B. HA activity
1. HA assay
Most of the HA assays were made in a Cooke microtitre system 
(Cooke Engineering Ltd.). To each well in a row except the first was 
added 0.05 ml of phosphate buffered saline (PBS, Appendix 2), The 
putative haemagglutinin was added to the first two wells in each row 
■(0.05 ml into each well) and doubling dilutions made from the second well 
in each row with microtitre diluters. After addition of 0.05 ml of a 
27. red blood cell suspension (usually horse red cells unless stated other­
wise) , the contents of the wells were mixed and the trays incubated for 
1 to 2 h at 37°C or left to settle for several hours at 4°C. The HA 
titre was recorded as the reciprocal of the last dilution giving complete 
HA. To distinguish between HA caused by F-HA and by pertussigen, HA 
assays were done in 50 mm x 13 mm tubes, as recommended by Irons & 
MacLennan (1979a), using t-en fold In volumes of reagents. F-HA induced 
HA was completely dispersed on gentle tapping of the tubes whereas that 
caused by pertussigen remained in clumps even when quite vigorously shaken,
2. Inhibition of HA
Two methods were used, the first involved mixing the inhibitor 
(either cholesterol or haptoglobin) with the HA and then proceeding with
I
the HA assay as described above and measuring inhibition as the reduction 
in titre. The second method was by titration of the inhibitor,
B. pertussis antisera, and adding a constant amount of HA. This was done
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by adding PBS 0,05 ml to each well except the first, inhibitor 0.05 ml 
was added to the first two wells in each row and doubling dilutions 
done along the rows from the second well. Eight HA units (HA suspension 
with HA titre of 8 ) were mixed with the contents of each well and the 
trays left at room temperature for 30 min. After this time, 2% horse 
red cells 0,05 ml were added to each well and the trays incubated as in 
the HA assay. The highest dilution of inhibitor to show complete 
inhibition of HA was the HA inhibition titre (HAI titre).
3. Cholesterol dispersions
Aqueous dispersions of cholesterol for use in the HAI tests 
were made as follows: 25 mg of cholesterol dissolved in 5 ml of
acetone was added to 25 ml of rapidly stirred distilled water heated at 
about 98°C on a hot plate/stirrer. Once the acetone had completely 
evaporated the dispersion was filtered through glass wool to remove 
large crystals. Fresh dispersions were always used.
4. Blending to remove F-HA
In order to remove fimbriae from B. pertussis cells 5 day 
static cultures were treated in an MSE blender at 14,000 rpm at 0°C for 
2 min. The cells (10 ml of a suspension of 50 ou^ are blended in a 
square bottomed universal attachment. Blending has been used to remove 
fimbriae from E, coli (Novotny e_t 1969). After blending, the cells 
were washed in CAD by centrifugation at 10,000 g and resuspended in CAD. 
Viability and HA titres of the cells before and after blending were 
compared,
Co Purification of the F-HA
1. Purification procedure
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Five litres of B. pertussis strain 77/18319 were grown in 
static liquid culture as used by Sato ejt ^  (1974) (Appendix 1).
After centrifugation at 10,000 g for 30 min at 4°C the pH of the culture 
supernatant fraction was adjusted with glacial acetic acid to pH 6,5 
and thiomersal added to a final concentration of 0.017. (w/v). The 
total volume of fluid was passed through CM Sepharose CL6B ion exchange 
resin (Pharmacia) in a column (2 x 40 cm) previously equilibrated with 
20 mM sodium phosphate buffer pH 6,5, The flow rate was approximately 
60 ml h Next, the gel column was washed with approximately 1 litre
of buffer to remove unbound material. The retained protein was eluted 
with 0.5M NaCl in 20 mM phosphate buffer pH 6.5 containing 57. v/v 
ethanol (Arai & Munoz, 1979a),and concentrated by ultrafiltration 
(Amicon Ultrafiltration Cell Model 52) with a YM30 hydrophobic membrane 
(Amicon). The concentrated protein (PEI) (approximately 200 pg ml ^) 
was mixed with equal volumes of a liposome suspension (Irons & MacLennan, 
1979a) and allowed to stand overnight at 4^C. The suspension was then 
centrifuged at 26,000 g for 1 h at 4^C which yielded a firm white 
pellet containing the lipid and adsorbed HA. The pellet was resuspended 
in 50 mM Tris/HCl buffer l.OM NaCl to half the volume of PEI added.
2. Liposome preparation
Liposomes were prepared as described by Irons & MacLennan 
(1979a), Chloroform solutions of egg yolk lecithin (28.8 mg, gift 
from Dr. J.H. Freer), dicetyl phosphate (3.18 mg. Sigma) and cholesterol 
(11.4 mg, Fisons) were dried as a thin film in a 100 ml round bottomed 
flask on the rotary evaporator (Rotavapor-R, Buchi). The dried lipids 
were resuspended by vigorous hand shaking in 8 ml of 50 mM Tris/HCl 
buffer pH 8 with l.OM NaCl and allowed to swell at room temperature for 
5 h with intermittent shaking. After 5 h, 8 ml of the PEI (200 pg ml ^) 
was qdded to the liposome suspension.
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5-day static culture supernate
I
pH adjusted to 6.5, 0.01% w/v Thiomersal added 
Applied to CM Sepharose CL6B column
washed
Bound protein eluted with buffered 0.5M NaCl/Ethanol
Eluate concentrated by YM30 ultrafiltration
Fimbrial haemagglutinin adsorbed onto Cholesterol-containing liposomes
Liposomes removed from suspension, washed and resuspended in 0.05M 
Tris/HCl buffer pH 8 with l.OM NaCl
liposome supernate protein 
(ISP)
Liposome adsorbed protein 
(LAP)
3o Polyacrylamide gel electrophoresis
The method used was based on that of Laemmli (1970) as 
modified by Ames (1974). Electrophoresis was done in the presence of 
sodium dodecyl sulphate (SDS). Separating and stacking gels contained 
respectively 11% (w/v) and 5% (w/v) acrylamide.
Both the gels and the buffers contained 0.1% w/v SDS. The
sample was prepared by mixing 1 volume of sample with 1 volume of
solubilizing buffer (Appendix 3) and heating at 100°C for 5 min. Samples
of 50 or 100 pi were added to each track in the gel. The buffers and
gels are described in Appendix 3.
4. Protein estimation
Protein estimations were done by the method of Lowry ^  
(1951) using Bovine Serum Albumin (Sigma) as the protein standards.
Whole cell protein was estimated using a derivation of the Lowry method 
described by Herbert ejb ^  (1971).
5, Assay for HSF activity
The component of B. pertussis called pertussigen (or 
pertussis toxin) is thought to be one of the toxic factors of pertussis 
vaccines (Pittman, 1979), Contaminating pertussigen may be responsible 
for the protective activity of F-HA preparations (Munoz et al, 1981).
For these reasons the histamine sensitising activity (which is a 
property of pertussigen) was estimated for fractions obtained in the 
purification procedure. Groups of 5 HAM/ICR mice of 7 weeks or older 
were used (under 7 weeks of age mice of this strain are much less 
responsive to HSF). Animals in each group were injected intraperiton­
eally (i.p.) with 0.5 ml of one of a series of graded doses of one of 
three fractions from the purification procedure’, PEI, LAP and the LSP.
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Five days later each mouse was injected i.p. with 3 mg of histamine 
dihydrochloride (Sigma) contained in 0.5 ml of saline. Survivors were 
counted 3 h after this challenge. The HSD^^ dose was calculated as 
described in section J.
Do Antiserum production
1. Antiserum against whole cells
A five day static broth culture of B. pertussis 77/18319 was 
harvested, washed and resuspended in saline to approximately 100 ou.
The bacterial suspension was mixed with an equal volume of Freund's 
incomplete adjuvant until a stable water in oil emulsion was obtained. 
The emulsion (1 ml) was injected into the muscle of each hind limb of a 
rabbit and on the fourth week 1 ml of the same antigen mixture was 
administered by i.p. injection. The rabbit was bled from the ear on 
the sixth week and the serum titrated for agglutinins. Two further 
i.p. injections were given at four weekly intervals before
the agglutination titre reached 8,000 when the rabbit was bled out by 
cardiac puncture. The blood was allowed to clot for 1 h at room 
temperature and then stored at 4°C overnight before the clear serum was 
collected and stored at -20°C.
2. Bacterial agglutination test
The method used was based on that of Preston (1970). Using 
the microtitre system, serial dilutions of serum were made in PBS as 
described for HA tests. To each well, 0,05 ml of a
bacterial suspension (30 ou ml) was added and the trays shaken at room 
temperature at 200 rpm on an orbital shaker for 5 min. The trays were 
then heated at 55^C for 30 min which allowed the trays to be read.
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immediately. The titre was recorded as the reciprocal of the highest 
dilution of serum to cause complete bacterial agglutination.
3. Antiserum to the F-HA
LAP (see purification procedure, p. 56) was mixed with an 
equal volume of Freund's incomplete adjuvant to form a stable water in 
oil emulsion. The emulsion (0.1 ml) was injected intradermally into 
each side of the rabbit above the scapula at two weekly intervals until 
each animal had received four pairs of injections. During the period 
of immunisation, HAI titres were determined from test bleedings taken 
from the marginal ear veins. Eight days after the final injections 
the rabbits were bled out by cardiac puncture and serum collected as 
described above.
4. Ouchterlony double diffusion in gels
The medium used for gel diffusion consisted of 1% agarose in 
50 mM Tris/HCl buffer pH 8 with l.OM NaCl (Munoz et al, 1981). The 
molten agar (20 ml) was poured into scratch free glass plates and 
allowed to harden and dry. The template was then cut which consisted 
of 5 mm wells 5 mm apart, 1 drop of molten medium was then added to each 
well to prevent leakage of reagents under the agar layer. Antiserum 
was added to the outer wells and incubated at 37°C for 30 min. The F-HA 
which was the antigen used was sonicated in an MSE ultrasonic disintegrator 
at an amplitude of 7 peak to peak microns for a total time of 2 min in 
20 sec bursts. The F-HA was kept on ice during the sonication.
Immediately after sonication the antigen was added to the centre well 
and the plates incubated at 37°C for 24 h after which time precipitin 
lines were obtained. The F-HA was sonicated to disperse aggregates which 
tend to form in the suspension giving diffuse precipitin lines in the gel.
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Eo Mouse infection and protection tests 
1. Sublethal intranasal infection
7
Bacterial suspensions were diluted to approximately 10 
- 1
colony forming units (cfu) ml . In the case of five day static 
cultures this required a 1/10 or 1/100 dilution of a 10 ou suspension. 
Usually both dilutions were used. Mice of either sex from a randomly 
bred closed colony originally derived from the Ham/ICR strain (Charles 
River, U.K. Ltd.), were anaesthetised with ether. Two drops of 
bacterial suspension (0,05 ml containing approximately 10^ viable 
organisms) were placed on the nose of the mouse and the mouse inhaled 
the inoculum. On day 14 after the instillation of bacteria the mice 
were sacrificed, and the lungs examined for pathological changes and 
samples taken for culture of B. pertussis. The lung pathology was 
scored on a scale of 0 to 4, 0 being no gross change in lung appearance, 
4 being almost complete consolidation with all the lobes infected. A 
small, piece of lung from the.middle lobe on the left side was removed 
from each mouse and spread onto a B-G plate. As with the pathology, 
the lung culture was scored on a scale of 0 to 4, 0 being negative, 4 
being confluent growth.
2o Passive protection against sublethal i.n. infection
Passive protective properties of antiserum against sublethal 
i.n. challenge and inhibition of infection by cholesterol was examined 
by mixing the antiserum or cholesterol dispersion with the challenge 
dose 30 min before infecting the mice. The infection was then carried 
out as above.
3. Intracerebral infection
To titrate i.e. virulence, challenge suspensions
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were made by suspending cells of B. pertussis strain 18323 in GAD to 
10 ou and dilutions made (10^, 10^, 5 x 10^, 2.5 x 10^) to give sus­
pensions with approximately 10^ cfu, 10^ cfu, 200 cfu and 40 cfu in 0.03 
mlo Each of the four dilutions were injected by the i.e., 
route into groups of 10 mice, viable counts were also done on the 
suspensions. The injection technique involved anaesthetising the 
mice with ether^ and using a fine needle (26 g 3/8 inch), 0.03 ml of 
suspension was injected through the parietal bone into the brain slightly
J
to the right of the mid line and about midway between the eye and the 
ear. The mice were allowed to recover from the anaesthetic and 
inspected daily for the next 14 days. Dead animals were removed and 
those showing unsteady gait or lethargy were killed. At the end of 
fourteen days the number of survivors in each group was noted and LD^^ 
values calculated.
4. Passive protection against i.e. challenge
As with the passive protection against i.n. challenges,
the highest i.e. challenge dose (10^ cfu) was mixed with
antiserum before the mice were injected. The infections were done as 
described previously. In each experiment the challenge was titrated 
using the dilutions described above.
5, Active protection against i.e. infection
The method used was a modification of the method described 
by Kendrick e^ ^  (1947). Groups of three week old mice were vaccinated 
i.p. with one of a series of graded doses of one of three vaccines 
tested. The vaccines tested were the Glasgow standard vaccine which is 
a whole cell vaccine, LAP and the LSP (p.Â^). Two weeks after
vaccination the mice were challenged with approximately 200 LD^^^ (10^ cfu)
/
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of 18323 the i.e. challenge strain. The values of the
vaccines were calculated as described in section J.
Fo Adhesion of bacteria to mouse lung
1, Assay by viable counting
Mice used for the adhesion assays were killed immediately 
before use by cervical dislocation, dipped in disinfectant and pinned 
out on a board. The rib cage was opened to expose and allow expansion
of the lungs. The trachea was carefully exposed by dissection, taking
care not to cause bleeding and a small incision was made to allow 
insertion of a cannula -through which 0,5 ml of bacterial suspension was 
instilled into the lungs. The cannula attached to 1 or 2 ml plastic 
syringes consisted of small tapered pieces of teflon tubing which 
fitted into the trachea but which were wide enough to seal the upper 
part of the trachea so that the instilled fluid did not escape via the
mouth. After the suspension had been in the lungs for the stipulated
time (30 min in most cases), as much of the fluid as possible was 
removed from the lungs via the cannula. The lungs were then washed 
out ija situ with 2 x 1 ml volumes of sterile CAD before being removed 
for further processing.
The percentage of the inoculated organisms retained by the 
lungs was determined by viable counts on the lungs after homogenisation, 
The excised lungs were washed in sterile CAD and then homogenised for 
30 sec in 10 ml of GAD in a Silverson multipurpose mixer-emulsifier.
The homogeniser blade assembly was sterilised before the start of the 
experiment and immersed in boiling water for 2 min followed by rinsing 
in cold distilled water after processing each set of lungs in a single 
experiment. This sterilization procedure was devised to prevent
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carryover of organisms from lung to lung. Viable counts were done on
dilutions of the whole lung homogenates and derived values were 
expressed as "percent of the original inoculum",
2, Assay with radiolabelled bacteria
The bacteria used in these experiments were grown in the 
medium described by Sato & Arai (1974) as previously described but 
containing 37 k Bq (^^C)-glutamic acid (Radiochemical Centre, Amersham, 
England) for 10 ml of medium. The radiolabelled organisms were used 
in the adhesion assay as with nonlabelled bacteria except that the 
excised lungs were put directly into 3 ml of Soluene 350 (Packard) and 
heated at 50°C for 2 to 4 h to dissolve them. After cooling to room 
temperature each solution was decolourised with 0.6 ml of propan-2-ol 
followed by 0.6 ml of hydrogen peroxide. After gentle shaking, the 
samples were left at room temperature for 15 min and then heated at 
40°C for 15 min followed by cooling to room temperature. Scintillant 
(10 ml) was added to each sample before counting. Duplicate samples 
of the inocula were counted (approximately 2000 counts), and to measure 
recovery, the radioactivity in the suspensions removed from the lungs 
and the. lung washings was also determined.
3. Variables in the adhesion assays
(i) Time - The relationship between time of exposure and extent of 
retention was determined by leaving the bacteria in contact with the 
lungs for times up to 1 h.
(ii)^2Ë “ pH 7 was the pH used in all the assays but the effect of 
varying the pH on retention was examined by suspending the bacteria in 
CAD at pH 6.5, pH 7.0 and pH 8,0, These other pHs were chosen because 
at pH 6.5 the F-HA adheres to a cation exchanger (Arai & Munoz, 197?a)
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and at pH 8.0 the F-HA is soluble in the presence of high salt concen­
trations.
(iii) Mouse sex - Groups of male and female mice were used in adhesion
assays to see if sex would influence the result.
(iv) Inhibition of adhesion - The bacteria were mixed with whole cell 
antiserum, antiserum raised against the F-HA or with cholesterol 
dispersions which inhibit HA caused by F-HA. Each mixture was then 
used in the assays as before. To study the ability of vaccination to 
cause inhibition of B. pertussis adhesion to the mouse lung, mice were 
vaccinated with a standard vaccine (Glasgow Standard supplied by
Prof. A.C. Wardlaw) i.n., i.p., or with F-HA both i.n. or i.p. To see 
if infection results in active protection against adhesion of bacteria, 
mice were given a sublethal i.n. infection and adhesion assays were
done on the mice at various times after infection,
(v) Alteration of surface charge - A postulated role for fimbriae in 
bacterial adhesion to epitheliaf cells is to allow the repulsive effects 
of like negative charges on the bacterial and epithelial cell surfaces 
to be overcome. The effect of reduction of the net charge of avirulent 
cells of B. pertussis (C mode and phase IV cells) on adhesion was 
investigated. The method of Heck&^s e^ a_l (1976) was used to remove 
carboxyl groups from avirulent non-fimbria ted gonococci. Heck^\s et al 
showed that the treatment to modify carboxyl groups reversed the original 
surface charge, increasing the pi value from 5.3 to 8.2, They.also 
showed the change in surface charge using cationised ferritin which 
reveals acid groups as electron dense regions, ferritin coating being 
heavy dn normal cells but scanty or absent on those with blocked carboxyl 
groups. The reagent used to modify carboxyl groups consisted of 500 mg 
of 1 ethyl-3-(dimethylaminopropyl)carbodiimide (EDC Sigma), 600 mg of 
methylamine hydrochloride (Sigma) and 5 mg of MgCl2H20 made up to 5 ml
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with the pH adjusted to 4.5 with l.OM HCl. A B. pertussis radiolabelled 
suspension was made in CAD to an optical density at A600 of approximately
1.0 and 5 ml of this suspension was added to the EDC solution. The 
mixture was stirred at 25°C and the pH readjusted to 4.5 with NaOH.
When the pH stopped falling the suspension was stirred for a further 16 h 
before the bacteria were recovered by centrifugation and washed in CAD. 
The washed bacteria were resuspended in CAD and stored at -70°C.
Go Hydrophobic interaction chromatography
Surface hydrophobicity of B. pertussis strains was measured 
as described by Smyth ^  aj^  (1978) but with minor changes. As with the 
adhesion assay, bacterial numbers were assessed by viable counting and 
by use of radiolabelled organisms. Suspensions of octyl sepharose 
(Pharmacia) were autoclaved and used sterile. Small columns were made 
by loading a pasteur pipette with 1 ml of the gel suspension (see Fig 4), 
The gel was washed in the pipette with 4M NaCl prior to addition of the 
bacteria (0,1 ml of 10 ou) which were allowed to drain into the gel.
The column was then eluted with approximately 5.0 ml of 4.0M NaCl in 0.02M 
Na-Phosphate buffer (P.B. )^pH 6.5, followed by 5.0 ml of 0.02M Na-P.B. 
pH 6.5.
When unlabelled organisms were used, the different eluates 
were collected and viable counts done on each as well as the starting 
material. If the bacteria were labelled then a sample of the material 
loaded onto the column was counted along with small volumes of each 
eluate. With the 0.02M P.B. 1 ml was counted in 10 ml of
scintillant (see Appendix 4) but with the 4.0M NaCl eluate it was 
necessary to reduce the salt concentration before counting. Therefore
0.25 ml of eluate was diluted to 1.0 ml with distilled water before
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sample and buffers added
pasteur pipette (I.D. = 5%m. )
Sepharose gel bed (approximately 0.6 ml 
gel bed volume)
glass wool
silicone rubber tubing 
clamp
eluates collected and viable counts 
or radioactive counts obtained
addition of scintillant and counting. The percentage of the organisms 
retained on the gel was calculated for each strain.
H. Assay of radioactivity
All samples were counted for 10 min in a Packard Tri Garb 300 
scintillation counter in 10 ml of
Triton-Toluene scintillant (Appendix 4), which was aged for 10 h before 
use. Samples containing Soluene 350 were left in the dark for several 
hours before counting and counted until stable counts were obtained.
I. Electron microscopy
The specimen and the negative stain which was 27. ammonium 
molybdate were mixed before being applied to a copper grid (mesh size 
400) coated with a formvar film 15-20 nm thick and the excess liquid was 
removed with a paper point. The specimens were examined in a Phillips 
300 microscope. Whole cells were chromium shadowed at an angle of 45° 
in an Edwards model E12 coating unit,
J. Statistical analysis
Results from HSF, i.e. virulence titrations and
mouse i.e. protection tests were analysed by the probit method
(Finney, 1952) using a computer programme developed in the Dept, of 
Epidemiology and Biometrics, School of Hygiene, University of Toronto, 
Canada. One sample was used as a standard and the potencies with 957. 
confidence limits of other samples relative to the standard were 
estimated. The ED^^ values of samples were also calculated,
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Results from sublethal i.n. experiments and passive 
protection experiments were analysed for significance at the 57. or 1% 
probability levels using tables for testing significance in 2 x 2 
contingency tables (Finney et al, 1963).
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RESULTS
Ao Growth and production of HA of Bo pertussis in vitro
The first step was to determine the conditions of the HA assay 
to be used throughout. The results from different incubation tempera­
tures and different blood types on HA titres of strains 77/18319 and 
77/19110 are shown in Table 4, Incubation temperature did not affect 
the titre within the range tested (4°G to 37°C). Therefore conditions 
for the HA assays were arbitrally set at 37°C for 1 to 2 h by which time 
the red cells had settled. Rat red cells gave slightly higher titres 
than human or horse red cells but the marginal increase in sensitivity 
was not sufficient to justify the inconvenience of using them in place 
of the readily available horse erythrocytes,
1, Solid medium
Two solid media were commonly employed for growth of B. pertussis, 
B-G agâr with added blood and charcoal agar. In a preliminary study 
several strains of B. pertussis were grown on B-G plates and charcoal 
plates and HA titres recorded. The results obtained with B-G cultures 
and charcoal cultures were similar (Table 5), There was no obvious 
pattern of HA as the time of incubation of the cultures increased, the 
titre varying from day to day. This was probably due to lack of 
standardisation of inoculum and therefore the stage of growth frôm plate 
to plate would be varied. No consistent differences were found among the 
9 strains studied. Differences were obtained however with the large 
and small colony types discernable in strain 77/18319, the large colony 
type having a lower HA titre than the small colony type (Table 7),
2, Liquid medium
(i) Shaken cultures - Cells were grown in Erlenmeyer flasks which were
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TABLE 5 : HA titres of different strains of B. pertussis grown on 
B-G medium
Strain HA titre of cells harvested from B-G plates after (h)
24 48 72
77/24833 32 4 4
77/26621 16 ND 8
77/19110 32 ND 8
77/18319 16 8 4
77/35296 16 ND 8
77/25171 16 ND 16
18323 2 8 ND
Mae no 4 8 ND
134 2 8 ND
Cell suspensions of 120 ou were' used, 
ND - not done
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dimpled to increase aeration efficiency. Under these conditions 
cultures reached stationary phase in approximately 48 h (Fig 5),
The inoculum in all cases consisted of 1,0 ml of a suspension of the 
growth from B-G plates resuspended in sterile CAD to approximately 40 ou. 
The HA titres in these liquid cultures fell quite quickly and by 48 h 
of incubation was reduced to ^  1 in both the cells and the supernate 
(Fig 5), No significant differences in the HA titres of different 
strains of B, pertussis were detected (Table 6), However and large and 
small colony variants of 77/18319 retained their different HA properties 
when grown in liquid medium. Fimbriae were rarely seen on cells from 
shaken culture when they were examined by electron microscopy. PAGE 
of freeze dried shake culture supernate showed no, or very little 
evidence, of the high molecular weight bands associated with F-HA 
(plate 1),
Cells of strain 77/18319 grown in C mode medium, where the 
N a d  was replaced by MgSO^, had no HA activity associated with either 
cells or supernate at any point during growth. The growth curves 
obtained for X and C mode cells (Fig 5) are similar. However after 
48 h, X mode cells tend to autoagglutinate which could be responsible 
for the subsequent reduction in adsorbance (A600) during stationary 
phase,
(ii) Static culture - In most purification procedures described for the 
F-HA, starting material came from static liquid culture. When cells 
of strain 77/18319 were grown in static culture for 5 days growth was 
obtained,although the adsorbance value for the stationary phase culture 
was only about half the value for stationary phase shaken cultures.
Most of the growth in X mode cultures formed a surface pellicle or stuck to 
the glass of the culture vessel. In the electron microscope cells from 
these cultures showed fimbriae-like protrusions on the cell surface
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Fig 5 : Growth and HA titres of X and C mode cells in
shaken cultures.
- X mode 
®  - C mode
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TABLE 6 ; HA titres of different strains of B. pertussis grown
in shaken culture
Strain of B, pertussis HA titre at 24 h
77/18319 16
18323 32
77/19110 16
77/25171 16
77/35296 32
77/24833 8
Cell suspensions were used at 240 ou
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Plate I : SDS-PAGE, of freeze dried B. pertussis liquid culture
supernates.
1 - X-mode 77/18319 static culture supernate
2 - X-mode 77/18319 shake culture supernate
3 - C-mode 77/18319 static culture supernate
4 - C-mode 77/18319 shake culture supernate
5 - X-mode 18323 static culture supernate
6 - C-mode 18323 static culture supernate
7 - partially purified F-HA
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1 2 3 4 5 6
TABLE 7 ; HA titres of large and small colony variants of
strain 77/18319 grown under different conditions
Culture HA titre with colony variant
Large Small
24 h B-G . < 2  16
18 h shake
(Hornibrook X mode medium) 2 8
96 h static
(Hornibrook X mode medium) <1 8
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(Plate 2)0 The HA titres of both the cells and the supernate from 
static cultures show an increase during the stationary phase between 
72 and 120 h (Fig 6 )* Under C modulating conditions in static liquid 
culture, no HA was produced. The growth of C mode cells in static 
culture never reached the density of X mode cells and no surface
pellicle was formed as it was with X mode cells. An HA positive
culture supernate was found to have completely lost its HA activity 
after shaking for 12 h under the growth conditions of the shaken 
cultures. This indicates that F-HA may be produced in shaken culture 
but destroyed by the shaking.
3. HAI by cholesterol
The final concentration of cholesterol used in these inhibition
studies was approximately 100 pg/ml. The HA caused, by both cells and
supernate of static cultures of strain 77/18319, was reduced when the 
same suspensions were titrated in the presence of cholesterol. With 
culture supernates, there was a 9/10 dilution of the original supernate 
after addition of cholesterol but this cannot account for the reduction 
in titre (Table 8 ). There was no significant reduction in the HA 
titres of either cells or supernate from 18 h shake cultures of strain 
77/18319. There was no significant reduction in the HA titre of strain 
18323 in the presence of cholesterol and as with shake cultures of strain 
77/18319 PAGE of freeze dried culture supernates showed little evidence 
of the high molecular weight bands corresponding to the F-HA (Plate 1).
4. Removal of F-HA from the cell surface by blending
(
Blending cells from static liquid culture in an MSE blender at
14,000 rpm for 2 min caused a significant decrease in the HA titres of 
the cells after washing (Table 8 ). These cells while losing the ability 
to cause HA remained viable.
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Plate 2 : ' Electron micrograph of chromium shadowed 5 day static
cells of B. pertussis strain 77/18319 (Mag x 68,000)
Fimbriae
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Fig 6 : Growth and HA titres of X and C mode cells from static 
culture,
m  - X mode 
^  - C mode
HA titres calculated on cell suspensions of 120 ou.
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TABLE 8 : Effect of cholesterol on HA titres of static and shaken
liquid cultures of strain 77/18319 and static cultures 
of strain 18323
Culture Source of HA HA titre with 
absent
cholesterol
present
120 h static 77/18319 cells 16 2
77/18319 supernate 8 2
77/18319 cells recovered 
after blending 1
18323 cells 32 16
18323 supernate 2 1
18 h shake 77/18319 cells 8 4
77/18319 supernate 2 1
Cell suspensions were used at 120 ou
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Bo Sublethal in. virulence of B. pertussis
The aim of these experiments was to assay the îau and in, 
virulence of several strains of B. pertussis and to investigate the 
possible interrelationship with HA and adhesion ability* For this 
purpose the in,virulent B. pertussis strains 44122/7R, 44122/7X and 
18323 were used, with the i,Cc avirulent strains 44122/7S, 77/18319 and 
18334 providing a contrast*
The assays showed that sublethal in. virulence of strains did 
not go hand in hand with the ic. virulence (Table 9)* Strain 18323 
although only tested in one experiment was less virulent by the in, route 
than any of the other strains tested except strain Taberman, With the 
variants of strain 44122/7 (44122/7R, 44122/7S and 44122/7X) which 
differed in ic. virulence, no difference was observed in their in. 
virulence. Strains 77/18319 and 18334 were as virulent by the in, route 
as the 44122/7 variants and more virulent than 18323 although they were 
both avirulent by the ic,route*
When the large and small colony variants of strain 77/18319 
were tested for in. virulence the small colony type seemed as though it 
may be more virulent than the large type although the results showed no 
significant difference (Table 10)*
1* Sublethal in. virulence of cells grown under different cultural 
conditions
HA activity was lost under C mode growth conditions, and when 
the cells were grown in shaken liquid cultures for 48 h (p 7 3 )*
C mode cells, 48 h shake culture cells and 120 h static cells of strain 
77/18319 were used in sublethal in. virulence experiments in an effort 
to determine the role of fimbriae in infection* The res,ults from two
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TABLE 10 ; Sublethal in. virulence of the large and small
colony types of B. pertussis strain 77/18319
Colony
Type
Inoculum
cfu
Lung Pathology^ Total
Small 3 X 10^ 
3 X 10^
1/5
4/5
5/10
Large 3 X 10^ 
3 X 10^
1/5
2/5
3/10»S
NS - no significant difference between large colony type and 
small colony type
1 - number of mice showing greater than 24- pathology/number 
of mice in group
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experiments are shown in Table 11* C mode cells were less virulent 
than the other types of cells tested* However in each group of mice at 
least one showed significant lung pathology* In experiments where 
infecting doses of around 10^ cfu per mouse were used, some mice infected 
with C mode cells showed 3 and 4+ lung pathology* Static liquid culture 
cells and shake liquid culture cells were equally virulent, showing 3 
and 4+  lung pathology with an inoculum of 10^ to 10^ cfu per mouse*
2* Effect of inhibitors and mechanical removal of fimbriae on mouse 
virulence of B* pertussis
Cholesterol inhibits HA by the F-HA of B, pertussis (Sato e_t al, 
1979; Irons & MacLennan, 1979a)* The HA activity of strain 77/18319 
when grown in static culture was inhibited by cholesterol dispersions 
(section A* 3)* Irons & MacLennan (1979a) reported that the HA assoc­
iated with pertussigen is sensitive to haptoglobin, a sialic acid 
containing glycoprotein* In early purification attempts made during 
this study, the F-HA and the pertussigen were partially separated on a 
sepharose 6B column, after the initial ion exchange column* Two peaks 
were obtained which both had HA activity* The protein from the first 
peak caused HA which was not sensitive to cholesterol. The red cell 
mat formed in this Instance was very tight and when the tubes in which 
the assays were done were tapped, the mat of agglutinated red cells 
resuspended in clumps. Haptoglobin (supplied by Dr* L. Irons, Porton 
Down) inhibited the HAj,and the remaining HA was as a fine mat which 
completely resuspended on tapping the tubes* The HA activity associated 
with the second peak was sensitive to cholesterol and the agglutinated 
red cells resuspended completely when the test tube was tapped* . Since 
these inhibitors were specific for one type of HA they are proposed as 
receptors for these HAs on mammalian cells* These two inhibitors were
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therefore used in mouse, virulence experiments to see if they might cause 
reduction of virulence in vivo as they do HA in vitro* Bacteria were 
mixed with the inhibitors and administered to the mice either intra- 
cerebrally (strain 18323) or intranasally (strain 77/18319) (Tables 12&13) 
Due to unavailability of purified haptoglobin, crude material (Cohn 
fraction IV from type 1 human plasma) was used as the inhibitor.
Tables 12 and 13 show that Cohn IV inhibited both in. and i.Cc virulence 
but whether this was due to the haptoglobin content was not determined* 
However in experiment 4 in the in. series, purified haptoglobin was used 
with some inhibitory effect* Cholesterol was inactive in both types of 
infection*
Blending of cells from static liquid cultures reduced the HA 
properties of the cells without reducing viability (Section A,4), These 
blended cells were also used in sublethal in, experiments but the blended 
cells were no less virulent than those which had not been blended (Table 
13).
Cc Purification and protective properties of F-HA
Five day static cultures of B* pertussis strain 77/18319, 
previously shown to produce fimbriae, were used as a source of the F-HA,
By day 5, the HA was found in the culture supernate* The HA titres, 
protein estimations and recovery of HA throughout the purification 
procedure are given in Table 14, There are no values for HA titres or 
specific activity for the LAP (as the liposomes made reading impossible). 
The protein estimation for the LAP is derived by subtracting the protein 
content of the LSP from the PEI* On centrifugation at 26,000 g for 1 h 
at 4°C the liposomes with adsorbed fimbriae formed a pellet and not a 
surface layer as described by Irons & MacLennan (1979a). However HA
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TABLE 12 : Effect of HA inhibitors on the if.virulence of 
B. pertussis strain 18323
18323 challenge Dose Deaths/ Relative potency
^^50
mixed with cfu Total (95% conf.limits) (cfu)
7250 9/10
no additive 725 10/10 1.0 22
145 10/10
29 5/10
950 9/10
Choies terol 190 9/10 0.79 28
38 6/10
(0.16,3.8)
900 8/10 '
Cohn fraction IV 180 6/10 0.12 180
36 1/10
(0,022,0.49)
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activity was removed from the suspension by the liposomes as evidenced
by the decrease in HA titre* Although a direct demonstration of HA
activity on liposomes was not shown, PAGE (Plate 3) of the sedimented
material showed that the high molecular weight bands characteristic of
B. pertussis fimbriae (Irons & MacLennan, 1979a) were found mainly in
the sedimented liposomes, whereas other proteins remained mainly in the
supernatant fraction. The PAGE pattern for the LSP showed 4 bands about
half-way down the gel similar to those described for purified pertussigen
(Irons & MacLennan, 1979b)* The bands in PAGE for the LSP are faint
due to the low amount of protein added, 3,5 pg compared to that added to
the tracks for the PEI and LAP of about 20 jig* PAGE of the LAP
preparation revealed very faint bands corresponding to pertussigen.
From PAGE evidence, chromatography on CM Sepharose CL6B retains mostly
F-HA with some pertussigen. The liposomes adsorb almost exclusively the
F-HA from the concentrated ion exchange column eluate (PEI). The large
diffuse band which moved with the buffer front was probably lipid, since
,it was found only in preparations containing liposomes (LAP), Electron
microscopy was done on the PEI and as can be seen from Plate 4 it
consisted mainly of short filaments (approx 20 x 40 nm) similar to those
described by Arai & Sato (1976) for the F-HA, Plate 5 shows only one band
between F-HA antiserum (1) and PEI in Ouchterlony double diffusion.
1* Histamine sensitizing activity of fraction with HA activity
Histamine sensitisation is a property of pertussigen and was 
used to monitor the pertussigen content of fractions from the purifi­
cation procedure, PEI, LAP and LSP were tested for their ability to 
sensitise mice to the lethal effect of histamine (HSD^q), Table 15 
shows the doses of each sample administered and the number of deaths in 
each group 4 h after ijp. injection of 3 mg of histamine five days later.
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Plate 3 : SDS-PAGE of F-HA at different stages of purification
1. - PEI
2. -' LAP
3. - LSP
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■ » . l ,  '
m
— - * Electron micrograph of a negatively stained sample 
of partially purified F-HA (PEI) (Mag x 107,000)
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«4 0 t 6 _
Plate 5 ; Ouchterlony double diffusion in agar of partially 
purified F-HA (PEI) against anti F-HA antiserum 
and whole cell antiserum,
1 - PEI
2 - F-HA antiserum 1
3 - pre immune serum
4 - Whole cell antiserum to strain 77/18319
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TABLE 15 : HSF activity of purified HAs from B. pertussis
Sample Ip, Dose 
(HS)
Deaths/Total HSD30
(Hg)
Relative Potency 
(95% Confidence limits)
PEI 10 5/5 •
2.5 4/5 1.2 1
0.625 1/5
0.156 0/5
LAP 16 2/5
4 0/5 19 0.065
(0.019, 0.18)
1 0/5
LSP 3.3 6/6 ,
0,825 5/5 0.26 4.8
(1.7, 13)
0.21 2/6
0.052 0/6
94
An HSD^Q value is also given for each sample with 95% confidence limits. 
The results show that the LSP whose PAGE pattern indicated that it 
contained pertussigen had a very low HSD^^ dose (0,26 pg). This 
indicates that some of the protein in the preparation was pertussigen.
The .LAP had a greatly increased HSD^^ dose and at the highest dose
tested (16 pg per mouse) some activity was detected but this dose was
less than 1 HSD^^ the value for that being calculated at 19,1 pg,
2, Active fè, protective properties of HA fractions
Immunisation of mice with fimbriae from B. pertussis has been 
reported to protect against ic. challenge, whereas immunisation with 
pertussigen does not (Sato et al, 1979), More recently these results 
have been disputed (Munoz et al, 1981), The F-HA (LAP) and pertussigen 
(LSP) preparations obtained from the purification procedure described 
were tested for their ability to protect mice against ic. challenge.
As with the histamine sensitising activity the LAP and the LSP were 
titrated for their ability to protect mice against approximately 200 LD^^ 
units of B. pertussis strain 18323, a highly ic. virulent strain. The 
results were computed using the same programme as for the HSF results to 
give protective dose^^ (PD^^ values. Results from two different lipo­
some preparations are given in Table 16, A  standard vaccine preparation 
was used for comparison. Protective activity was ,associated with both 
fractions.
3, Passive ic. and in, protection by anti F-HA
The LAP preparation was used as an immunogen in rabbits for 
of
preparation^antisera to the F-HA, The anti HA properties of the F-HA 
antisera, whole cell antiserum to 77/18319 and US standard antiserum
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were tested (Table 17). Antiserum (1 )to F-HA showed the greatest
ability to inhibit HA. To test the ability of anti F-HA to protect
mice against pertussis infection, the antiserum (1) was mixed both with
a sublethal in, challenge dose and with an Ic; challenge dose. Passive
protective activity against sublethal in, infection was estimated by the
ability of antiserum to reduce or inhibit completely lung consolidation.
Good protection against lung consolidation was observed with the highest
dilution of F-HA antiserum (1) tested (1/50) (Table 18), With fc.
challenge F-HA antiserum (1) showed protective activity when used 
as a
undiluted or/1/2 dilution but at the 1/5 dilution the protective 
activity was already decreasing, F-HA antiserum (1) was less protective 
than either whole cell antiserum to strain 77/18319 or the US standard 
antiserum (Table 19), F-HA antiserum (2) which had an HAX titre equal 
to that for the whole cell antiserum was not protective even when
undiluted. This indicates that although F-HA antiserum was protective,
/
the anti HA is probably not the important protective antibody in whole­
cell antiserum.
The ability of F-HA antiserum (1) to neutralize the histamine- 
aensitising property of a standard vaccine was examined in order to 
check the specificity of the antiserum. It was decided to check the 
neutralization of histamine sensitization as pertussigen may have been 
a small contaminating factor in the antigen preparation. The results 
show (Table 20) that F-HA antiserum (Î) did not have the ability to 
neutralize approximately 1 HSD^^ dose of a standard vaccine. In 
contrast, the antiserum to whole cells of strain 77/18319 did neutralize 
1 HSD^q dose,
4, Ability of 77/18319 F-HA antiserum to protect against non-fimbriated 
77/18319 and other strains of B, pertussis
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TABLE 17 : HAI activities of different P-HA antisera, whole cell
antiserum and the US standard antiserum
Antiserum HAI titre HAI units^
US standard 8 64
Whole cell antiserum
to B. pertussis 2 16
strain 77/18319
F-HA antiserum (1) 64 512
\
F-HA antiserum (2) 2 16
1 - HAI units are HAI titre x no of HA units the antiserum 
is inhibiting, i.e. 8 ,
98
TABLE 18 : Passive protective activity of antiserum to F-HA in the
sublethal iji* infection with B. pertussis strain 77/18319
Antiserum Dilution Lung Pathology^
2
Lung Culture
No antiserum 29/33 22/26
Undiluted 1/25** 1/22**
1/5 4/25** 7/24**
1/10 3/25** 7/25**
1/50 7/20** 9/20**
The values in the table are the additive results of 4 separate 
experiments.
The inoculum/mouse varied from 4.8 x 10^ to 7 x 10^ cfu,
1 - number of mice showing greater than 2+  lung pathology/
number of mice in group,
2 - number of mice showing greater than 2+  lung culture/
number of mice in group,
** - significantly different from no antiserum control at the 
17o probability level,
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TABLE 19 : Passive protective activity of F-HA antiserum (1) and
two anti-whole
150 LD._ of B. 50s —
cell sera against 
pertussis strain
ip. challenge with 
18323
Antiserum Dilution Survivors/Total
none 1/10
anti F-HA (1) Undiluted
1/2
1/5
9/10**
10/10**
4/10^^
Anti-whole cell 
77/18319 static
Undiluted
1/5
1/10
10/ 10**
8/ 10**
9/10**
US s tandard 
anti-pertussis sera
Undiluted
1/5
1/10
8/ 10**
8/ 10**
9/10**
** - significantly different from no antiserum control at 1% 
probability level 
NS - not significantly different from no antiserum control
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TABLE 20 : Anti histamine sensitising activity of F-HA antiserum (1)
Vaccine/mouse 
(ou of Glasgow
Standard) Antiserum Dilution Deaths/Total
1.3 None - 10/10
0.65 None - 7/10
0.325 None - 0/10
0.65 F-HA (1) 1/2 10/ 10^^
1/4 7/10^^
0.65 Whole cell 1/2 2/ 10*
antiserum to
strain 77/18319 1/4 7/10^^
* - significantly different from 0.65 ou of vaccine control at 5%
probability level 
NS - not significantly different from 0,65 ou of vaccine control
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Bo pertussis strain 77/18319 when grown in shaken culture for 
48 h had no HA activity and there was no evidence of
fimbriae on the cell surface. However these cells were found to be 
intranasally virulent and the ability of F-HA antiserum to protect 
against sublethal i.n. infection by these cells was examined.
The results show (Table 21) the antiserum to be protective.
Whether or not there is any antigenic variation in fimbriae 
from different strains of B, pertussis is not known. Before a fimbrial 
vaccine could be used its effectiveness against a large number of 
strains would need to be tested. The strain used to challenge 
immunised mice intracerebrally (18323) was different from the strain 
from which the fimbriae were derived (77/18319) yet the mice are 
protected (Results Table 16), Similarly some passive protection was 
afforded mice challenged intracerebrally with 18323 where the anti F-HA 
was derived from strain 77/18319 (Results Table 19), Another strain 
commonly used in our laboratory, 18334, was used as a sublethal 
i.n. challenge in a passive protection test using anti F-HA from 
77/18319, The results (Table 21) show that the antiserum protects 
against this challenge.
Do Adhesion of B, pertussis to mouse lung
An intra-tracheal infusion technique was used to study the 
affinity of B. pertussis for murine pulmonary epithelium.
The effect of various times of exposure on the adhesion or 
retention level of B, pertussis in mouse lung was studied over the period 
0 to 60 min and using both viable- counting and radioactive counting 
methods. Fig 7 shows that the percentage of infused bacteria retained 
in the lung increased up to 30 min after which it levelled off, both
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TABLE 21 ; Protection by antiserum to F-HA from static cultures of
77/18319, against sublethal in. infection by B, pertussis 
strain 77/18319 from static and shake cultures and against 
strain 18334 from static culture
Culture or mixture 
used for inoculum Lung Pathology^
2
Lung Culture
77/18319 static 16/17 (3 died) 11/12
77/18319 static with 
F-HA antiserum (1) 1/20*>V 1/17**
77/18219 shake 12/16 (4 died) 7/11
77/18319 shake with
F-HA antiserum (1) 1/20** 3/15*
18334 static 16/17 (3 died) 11/12
18334 static with
F-HA antiserum 0/20** 1/18**
Inoculum in cfu approximately 5 x 10^ in all cases
1 - number of mice showing greater than 2+  lung pathology/number of
mice in group
2 - number of mice showing greater than 2+  lung culture/number of
mice in group. Discrepancy in numbers/group between pathology 
and culture due to contamination of’ plates
** - significantly different from no antiserum controls at the 1% 
probability level
* - significantly different from no antiserum controls at the 5%
probability level
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Fig 7 : Percentage adhesion of B, pertussis strain 77/18319
to mouse lung as the time of exposure is increased
■  “ Radioactive counting method
#  - Viable counting method
Points are plotted with bars representing 1 SD.
104
26
24
22
co
(ÿ)
(D
_C
"0
<
a?
20 30 40 50 602 10
Time (min)
methods giving similar results. It was decided that 30 min was a 
satisfactory time and was therefore used in most subsequent experiments» 
From Figs 7 and 8 it can be seen that there seems to be two phases to 
the adhesion or retention of B» pertussis to mouse lung» An initial
fast rate of adhesion in the first 0 to 2 min after which the rate of
adhesion is much slower. The rate of adhesion of X and C mode cells
is in two phases (Fig 8 ), The initial rate of adhesion between 0 and
10 min where the virulent X mode cells adhere at a much faster rate 
than the avirulent G mode» The second phase of adhesiom being between 10 
and 30 min where both X and C mode cells adhere at similar rates.
Strain 77/18319 on different occasions gave different values 
for percentage adhesion (Figs 7 & 8 )» This could possibly have been 
due to variations in the cells from culture to culture which caused 
the cells to have different abilities to adhere. To ensure variation 
in inoculum size was not responsible for this variation three ten-fold 
dilutions of strain 77/18319 were used in lung assays and the results
are showm in Table 22» No difference in the percentage of organisms
adhering was found, indicating that a culture of B. pertussis has a 
fixed proportion of organisms which can adhere.
The sex of mice used in the adhesion assays had no effect 
on the adhesion of B, pertussis strain 77/18319 (Table 23), The mice 
were used at between 5 and 8 weeks of age, as at 3 weeks, the age the 
mice were used at for sublethal in, virulence experiments, they were 
too small to allow the cannula to be inserted into the trachea,
1, Adhesion of virulent and avirulent B, pertussis
C mode and phase IV cells lack HA activity and are avirulent.
The ability of these variants to adhere to mouse lung was compared with 
their X mode phase 1 counterparts (Table 24), The C mode and phase IV
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Fig 8 : Percentage adhesion of X and C mode cells of 77/18319 with
different times of exposure to mouse lungs
H  - X mode -
^  - C mode 
Viable counting method used
Points are plotted with bars representing 1 SD.
106
50-
40-
c30
o
m
CD_c
■ D<
20
/
/
/
/
10-
5 -
10
Time (min )
30
TABLE 22 : Effect of 10 fold increases in inoculum size of 
strain 77/18319 on percentage adhesion in mouse 
lung assay
Inoculum size (cfu) % Adhesion—  1 SD
2 X 10^ 15.8 ~ 3.25
2 X 10^ 19 - 0.5
2 X 10^ 16.5 - 5.5
Viable counting.method used
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TABLE 23 : Effect of mouse sex on adhesion of B. pertussis 
strain 77/18319 to mouse lung
Sex 7o Adhesion ^ 1 SD
Male 23,5 ^  5.06
Female 24.8 ^  4.72
Viable counting method used
108
TABLE 24 : Percentage of the inoculum of virulent and avirulent 
variants of B. pertussis strains 77/18319 and D30042 
adhering to mouse lung
Inoculum % Adhesion ^  1 SD
77/18319 X mode 31.3 - 4.0
77/18319 C mode 6 ± 1.6
D30042 phase I 20.6 t 0.3
D30042 phase IV 3„5 - 1.8
77/18319 Small 4.
colony variant 22 - 2
77/18319 Large 4_
colony variant 10 - 2.6
Viable counting method used
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cells were much less able to adhere than X mode phase 1 cells. Another 
set of HA positive and HA negative cells are the small and large colony 
variants of 77/18319. With these cells the HA negative, less virulent 
large colony type showed a lower level of adhesion than the small colony 
type (Table 24).
Other strains which differ in virulence properties were also 
used in adhesion assays. These strains were 44122/7R, ic.virulent, and 
44122/7S which is ic. avirulent. Both these strains are equally 
virulent by the in. route. Strain 18323 was also used, this strain 
being i.c, virulent but less i»n, virulent than 77/18319. The values obtained 
for percentage adhesion to mouse lung do not reflect the ip,virulence of 
the strains but seem to relate to the sublethal in. virulence (Table 25),
The values obtained for percentage adhesion for strain 77/18319 
for the two experiments illustrated (Table 25) are very different although 
the same batch of cells were used for both experiments. This was 
probably due to the chemiluminescent effect of the soluene which had 
been allowed to decay for several days in the dark in the 44122/7R,
44122/7S, and 77/18319 experiment, but only for approximately 24 h in the 
77/18319, 18323 experiment. This phenomena was found throughout the 
radioactive experiments when the vials had been left standing in the dark 
for several days the percentage adhesion to the mouse lung seemed to 
decrease. Each experiment was therefore treated individually and an 
internal standard always included usually strain 77/18319 X mode cells.
2 o Effect of prior vaccination of the mice on adhesion of B. pertussis 
to mouse lung
Experiments where groups of mice were vaccinated ip, before use 
in the adhesion assay with the Glasgow standard vaccine, or infected fn,
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TABLE 25 : Adhesion of different strains of B. pertussis to mouse 
lung
Strain Percentage Adhesion - 1 
1
SD in Expt No. 
2
77/18319 22.3 - 4.8 12.3 t  4.1
18323 11.7 - 2.3 ND
44122/7R ND 13.6 - 2.9
44122/7S ND 14.2 3.7
Radioactive counting method used
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were done. On day 14 after vaccination a group of mice were sacrificed 
and used in an adhesion assay. This was repeated on groups of mice on 
day 31, 33 and 43 after vaccination. The results obtained (Table 26) 
show no change in the percentage of the inoculum adhering to the lungs 
compared to control animals tested over this time period. Mice which 
had been sublethally infected were sacrificed on days 31, 33 and 43 for 
adhesion assays. A  control group were sacrificed on day 14 to ensure 
the mice had been infected. The level of infection was very low, 
giving lung pathology scores of 1 or 2+. Infected animals on all 
three days showed evidence for some reduction in the adhesion level 
compared to control and vaccinated animals although this reduction was 
not significant.
The effect of vaccination with fimbrial preparations, as 
compared to standard whole cell vaccines, on adhesion was studied (Table 
27). Groups of mice were vaccinated intraperitoneally or intranasally 
with either F-HA or the Glasgow standard vaccine. Although the results 
obtained were variable they do indicate 1) that F-HA given intraperi­
toneally inhibits subsequent adhesion of B. pertussis to the lungs;
2) although the level of protein administered was very low, the F-HA given 
intranasally also seemed to cause ai inhibition of adhesion; 3) the whole 
cell vaccine showed little inhibitory activity against adhesion to lungs. 
With whole cell vaccine and F-HA administered intranasally very little 
can be said about the results as the dose administered by this route was 
only 10  ^ of that administered intraperitoneally.
3. Effect on lung adhesion of mixing the bacteria with F-HA inhibitors
Passive inhibition of adhesion was studied by mixing rabbit 
antiserum to whole B. pertussis cells and antisérum to the F-HA 
preparation with the inoculum into the mouse lung. The results showed
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TABLE 26 : Effect of prior infection or vaccination, with a standard 
vaccine, of the mice, on adhesion to mouse lung after 
30 min exposure
Mouse treatment Day after treatment 7o Adhesion ^  1 SD
None 14 16.5
+
1.8
31 14.5 t 3.4
33 17.5
+
4.7
43 15,5
+
2.4
Vaccinated 14 17.3
+ 2.3
2 ou ml of Glasgow 31 12.4
+
2.1
Standard/mouse 33 17.1
+
3.2
' 43 14.3
+
1.5
Infected sublethal 41 11.4 t 1.8
i,n, dose (6 x 10^ cfu)^ 33 15.5
+
1.0
43 12.9
+
2.6
1 - number of mice showing greater than 24- lung pathology/total number 
of mice in group was only 1/10 
Radioactive counting method used
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TABLE 27 : Effect of prior vaccination by a purified F-HA
antigen or a standard vaccine on subsequent adhesion 
to mouse lung
Antigen 
(lag protein/ 
ml)
Route of 
Antigen 
adminis­
tration
Dose (ml)
(jig protein)
% Adhesion ^  1 SD in 
Expt Nos
1 2
LAP (26) 0.5 (13) 5.5 - 2.1 12.7 - 2,8
VI* 0.05 (1.3) 9.5 t  3.9 13.2 - 2.4
Glasgow 
Standard 
Vaccine (60)
ip.'
in.
0.5 (30) 
0.05 (3)
11.53 - 3.6 
10.3 - 4.6
14.7 - 4.4 
15.4 - 3.2
None - ' 13.8 - 3.1 17.0 - 2.9
Radioactive counting method used
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evidence of inhibition of adhesion by the F-HA antiserum but not with 
the whole cell antiserum (Table 28). The F-HA inhibitor cholesterol 
showed no ability to decrease the adhesion to mouse lung when mixed with 
Bo pertussis before inoculationo
J
4o Effect of varying the bacterial cell surface charge on adhesion 
to mouse lung
The net charge of proteins can be altered by changing the pH of 
the suspending fluid. The pi value of the F-HA is not known but its 
retention on CM Sepharose at pH 6.5 indicates a positive charge at this 
pHo It is assumed the lung epithelial cells will, like other mammalian 
epithelial cells, be negatively charged. The effect of reducing the 
negative charge of B. pertussis by causing the fimbriae to be positively 
charged was examined. The percentage adhesion decreased when the pH 
was increased in the suspending fluid from 6.5 to 7.0 (Fig 9), This 
increase in adhesion cannot be directly attributed to the F-HA as 
other surface proteins may be affected by this pH and may be involved 
in adhesion.
Another method used to show that fimbriae are involved in 
adhesion by overcoming the repulsive forces of the like charges on the 
bacterial and mouse cells was by reducing the net negative charge of 
the bacterial cells. If fimbriae act to overcome these repulsive 
forces then non-fimbriated bacteria, when their negative surface charge 
has been reduced, should be able to adhere to the mouse lungs. In a 
preliminary experiment C-mode and phase IV cells were treated by the 
method of Heck^ls £t al (1976). It was found that these treated cells 
adhered to a much greater extent than untreated C mode or phase IV cells.
E. Hydrophobic interaction chromatography of B.' pertussis
Smythe e_t ^  (1978) using HlG showed that strains of E. coli
U 3
TABLE 28 : Effect on adhesion to mouse lung of mixing
Bo pertussis strain 77/18319 with antiserum or 
cholesterol before inoculation
Inhibitor 7o Adhesion ^  1 SD
None 24.6 - 4.1
Whole cell antiserum
to B, pertussis 24.7 - 5.2
strain 77/18319
F-HA (1) antiserum 19.0 - 4.5
Cholesterol 23.1 - 3.9
Radioactive counting method used
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Fig 9 : Effect of pH of suspending fluid on the percentage of
cells (77/18319) adhering to mouse lung.
Radioactive counting method used
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with K88 and K99 fibres on the cell surface were more hydrophobic than 
K88 and K99 negative strains, HlC is a chromatographic procedure based 
on hydrophobic interaction between nonpolar groups on a gel bed and non­
polar regions of proteins. The gels were run in high ionic strength 
buffer to inhibit any ionic binding^decreasing the ionic strength of the 
running buffer allows desorption of the less strongly adsorbed 
substances,
No data are available on the surface hydrophobicity of virulent 
and avirulent strains of B, pertussis. The two commonly used avirulent 
variants of B, pertussis are C modulated and phase IV variants. Two 
sets of cultures were used in HlC, X and C mode cultures of 77/18319 and 
phase X and IV of strain 030042, As indicated by the results (Table 29) 
virulent X mode or phase I organisms are much more hydrophobic than are 
the G mode or phase IV cells as evidenced by their increased retention 
on octyl sepharose. Even after washing with low ionic strength buffer 
(PB) a small percentage of X mode and phase I organisms were desorbed
from the gel bed. The large colony variant of B, pertussis strain
77/18319 which was found to be less virulent than small colony types 
was also less hydrophobic by HlC as evidenced by the small percent of 
the cells which adsorbed to the gel bed.
The hydrophobicity of organisms varying in i.n. 
and in i.c. virulence (see Results Section B) was assessed on columns
of octyl sepharose (Table 30), The strains used which were intra-
cerebrally virulent were 44122/7R, and 18323, the other strains 77/18319,#%^ 
44122/7S were avirulent. The i.e.' virulence of strain
Taberman is not known. The i.n. virulence of the strains also 
varied and decrease in the order 77/18319, 44122/7R and 44122/7S ^
18323^ Taberman, Strains 77/18319 and 44122/7R were the most hydro- 
phobic followed by 44122/7S, 18323 and Taberman,
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TABLE 29 : Retention of virulent and avirulent B, pertussis
on octyl sepharose gel
Culture Virulence 7o Eluted by % Retained on
4M NaCl PB column
77/18319 X mode + 10.4 2.2 87,4
77/18319 C mode - 50 21.6 28.4
D30042 phase I + 20.4 1.8 77,8
D30042 phase IV - 64.1 3.5 32.4
77/18319 Small 
colony variant + 10.2 ND 89.8
77/18319 Large 
colony variant +  - 43 ND 57
All cultures were five day static cultures
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TABLE 30 : Elution and retention by octyl sepharose gel of
different strains of B. pertussis
Strain Virulence 
ic, in.
7o Eluted by % Retained
4M NaCl PB
77/18319 - + 10.4 2.2 87.4
Taberman ND +  - 25.2 2.5 72.3
18323 + +  - 22.7 0.2 77.1
44122/7R + 9.5 2.5 88
44122/7S
_1
+ ' 19.0 3.5 77.5
1 - Personal communication from Mr. Salah al Salami
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When B. pertussis cells are grown in shaken culture 
HA ability is lost and no fimbriae can be seen on the cell surface.
However the cells had a similar level of i.n. virulence as
statically grown cells. The hydrophobicity of cells from shaken 
cultures was compared with that of statically grown cells and as the 
results show (Table 31) there was a reduced ability to stick to octyl 
sepharose but the level was not as low as with avirulent C mode cells 
which also lack HA ability and lack fimbriae.
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TABLE 31 : Effect of cultural conditions on the retention of
Bo pertussis by octyl sepharose gel
Growth Condition % Eluted by % Retained
of strain 77/18319 4M NaCl PB
Static 12.2 2o3 85.5
Shake 45.7 1.0 54.3
C mode 50,0 21.6 28.4
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DISCUSSION
A. Production of HA and virulence of B. pertussis
1. Production of HA
The strains of ,B. pertussis tested from B-G cultures showed 
very little difference in HA titres obtained. Changes were found when 
the cells were grown under different cultural conditions. When grown 
in shaking cultures the HA titre was maximal at 18 h and was on most 
occasions completely lost by 48 h. In static culture however the HA 
titre of the cells increased up to 96 to 120 h incubation. These 
results agree with those obtained by Arai & Munoz (1979b) who examined 
the HA titres of cells grown in different media and in different 
cultural conditions.
The growth curve for X-mode and C-mode cultures in shake 
cultures are similar for the first 48 h. As the growth reaches 
stationary phase, the adsorbance (A6G0) of the X-mode cultures starts 
to drop slowly. This is probably due to the clumping of cells. In 
static liquid culture the X-mode culture grows mpre than the C-mode 
cultures. When a 4 day static X-mode culture was transferred to a 
dimpled Erlenmeyer flask and incubated on an orbital shaker the cells 
tended to form clumps. It is possible that the cells forming the 
clumps in shake cultures and those in the shaken static cultures are 
hydrophobic and fimbriated and due to these surface properties the cells 
stick together. Static culture supernate which was HA positive com­
pletely lost its HA titre after 12 h shaking in a dimpled Erlenmeyer 
flask at 37°C. This indicated that HA released into the supernate in 
shake cultures was destroyed or inactivated in some way. It is possible 
that fimbriae are produced in shake cultures but most of the cell 
associated fimbriae and the HA released into the culture supernate are 
destroyed by the shaking.
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2o Inhibition of HA
The HA activity of the fimbriae was inhibited by cholesterol 
whereas that caused by pertussigen was not inhibited (Irons & MacLennan, 
1979a; Sato e^ al, 1979). The two HAs were distinguished in the 
present study by incorporating cholesterol into the HA tests. The 
results (Table 8 ) show that for strain 77/18319 in static culture both 
the cell free and cell-associated HA activity was sensitive to cholesterol, 
The cell-associated HA activity was also sensitive to mechanical shearing 
in a blender. With 18 h shake cultures cell-associated and cell-free 
HA activity was reduced only slightly when titrated in the presence of 
cholesterol. This perhaps reflects a lower level of F-HA in shake cult­
ures compared to that in static cultures. Strain 18323 an intracere- 
brally virulent strain, does not even when grown in static culture show 
any significant reduction in HA titre in the presence of cholesterol.
3. Virulence of 'B. pertussis
The static and shake cultures of strain 77/18319 with different 
levels of HA activity were used in mouse sublethal i.n. virulence 
experiments (Table 11) along with blended static cells. The shaken 
cultures and blended cells with very little or no detectable HA titres 
were as virulent as the static cells which had positive HA titres. If 
the fimbriae are important in adhesion it would have been expected that 
the cells without fimbriae would be less able to adhere and be swept 
away by the clearing mechanisms in the lungs. The fact that non­
fimbriated cells were as virulent as fimbriated cells would suggest 
either that (a) fimbriae are not necessary for adhesion and virulence 
in the mouse lung assay or (b) the cells are triggered by the lung 
environment to produce fimbriae. In E. coli there is an intracellular 
pool of common type 1 fimbriae subunit protein (Brinton, 1965). When
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E. coli was blended to remove the fimbriae they regenerated very quickly, 
the numbers returning to control level 1 to 4 min after blending 
(Novotny e± 1969). It is also possible that there is a second 
mechanism of adhesion, perhaps involving the HA property of the 
pertussigen component.
Strain 18323, which has a low cholesterol-sensitive HA titre 
when grown in static culture but a greater cholesterol-resistant HA 
property than strain 77/18319 (Table 8 ), is less virulent by the i.n, 
route than strain 77/18319 (Table 9). As strain 18323 is i.c. virulent 
and strain 77/18319 is not, it would seem that the F-HA is not of great 
importance in i.e. virulence. However the low level of fimbriae 
present on strain 18323 may be sufficient to allow some organisms to 
adhere and initiate infection. After this point another factor must 
be responsible for i.c. virulence. Strain 77/18319 may adhere in the 
mouse brain but either (a) not have a specific factor required to allow 
multiplication, (b) not have a toxic factor required to cause death or 
(c) it may multiply in the brain but be overcome by the mouse protective 
factors whereas 18323 evades these factors. As anti F-HA antiserum and 
vaccination with F-HA extracted from 77/18319 shows protective activity 
against i.c. infection with strain 18323 it would seem that the fimbriae 
are probably involved in adhesion in the brain.
In lung infections, the presence of fimbriae may be more 
important in virulence since the poorly fimbriate strain 18323 is less 
virulent than the more richly fimbriate 77/18319. However when static 
and shake cultures of strain 77/18319 were used, this correlation did 
not appear to hold. It is likely however that shaken cells have the 
ability to regenerate fimbriae when environmental conditions are 
favourable as may occqr in the lung. The lower i.n. virulence of
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strain 18323 may reflect the lower numbers of fimbriae in this strain, 
which in turn may reduce its adhesive capacity in the respiratory tract.
Adhesion would seem to be more important in mouse lung 
infections than in i.e. infections. This is supported by the large 
inoculum required for lung infection as compared to the i.c. value
for strain 18323 of 22 to 68 cfu. In i.e. infection 90% of the inoculum 
into the brain is immediately lost into the blood stream (Dolby & 
Standfast, 1961). It is probable that 2 to 7 cfu retained in the brain 
are sufficient to cause eventual death of the mouse.
Two variants of strain 44122/7 differ in streptomycin resist­
ance (7R being resistant and 7S sensitive) and also in i.c. virulence 
(7R virulent, 78 avirulent). A transformant of 44122/78 (transformant 
X prepared by Mr. 8 . al Salami, Dept, of Microbiology, Univ. of Glasgow) 
gained i.c. virulence along with streptomycin resistance. These three 
variants 44122/7R, 44122/78 and 44122/7X were all tested for HA activity. 
No difference was detected in HA activity or the sublethal i.n. virulence 
of these three variants of strain 44122/7 (Table 9). This provides 
additional evidence for the view that different cellular components 
are responsible for mouse virulence of B. pertussis by the i.n. and 
i.c. routes.
4. Hydrophobicity of B. pertussis
The technique of HIC was used to compare the hydrophobicity 
of different strains and cultures of B. pertussis. Strains Taberman, 
44122/78 and 18323 were all slightly less hydrophobic than 77/18319 and 
44122/7R, Strains 18323 and Taberman are also both less intranasally 
virulent than 77/18319 and this reduced surface hydrophobicity could 
account for this. However strain 44122/7S is as virulent by the i.n. 
route as strains 77/18319 and 44122/7R, The hydrophobicity of the cell
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surfaces could be related to more than one surface factor, • As strain 
18323 is less fimbriate than strain 77/18319 it would seem possible that 
fimbriae play a role in surface hydrophobicity. However as 44122/7R 
is more hydrophobic than 44122/7S it is possible that a factor involved 
in i.c. virulence is a hydrophobic surface component.
Table 31 shows the degree of retention, of cells of strain 
77/18319 grown in static culture (HA positive) and grown in shake 
culture (HA negative), on octyl sepharose. C mode cells were used as 
a comparison of cells with a low hydrophobic nature. The results show 
three levels of retention; (a) the static cells with high retention 
properties; (b) the G mode cells with a low level of retention and 
(c) the shaken cells with a percentage retention between these two 
values. Static and shake X-mode cultures were equally virulent but 
differed in HA properties and in hydrophobicity. This indicates that 
fimbriae confer hydrophobicity on the cells. However when the fimbriae 
were lost from virulent cells the level of hydrophobicity did not drop 
to the level of avirulent cells. This suggests that differences in 
outer membrane proteins may also affect the hydrophobic nature of the 
cell surface. A hydrophobic outer membrane protein could therefore 
be involved in adhesion.
Fimbriae have been shown to play an important role in adhesion 
of the gonococcus and various other bacterial parasites of mucous 
surfaces. Gonococcal fimbriae contain 46% non polar amino acid 
residues and, as such, are reported to play a dominant role in the gono­
coccal surface hydrophobicity (Watt & Ward, 1980). However, when whole 
gonococci were interacted with hydrophobic gels, fimbriate cells only 
showed a 20% increase in retention on the gel compared to non-fimbriate 
cells. Watt & Ward (1980) interpret this result as implicating the
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surface of the gonococcal outer membrane itself in hydrophobic binding. 
Smyth £t al (1978) reported that the fimbrial-like K88 antigen was 
solely responsible for binding of smooth enteropathogenic E. coli to 
hydrophobic sepharoses.
The possible relationship between i.c. or i.n. virulence, 
hydrophobicity, and the presence of fimbriae on different strains of 
Bo pertussis was a central theme in this investigation. If the hydro­
phobicity of non-fimbriated cells is a reflection of virulence by either 
route, then hydrophobic outer membrane proteins may be responsible for 
virulence as would seem possible from the preliminary results obtained 
here, Pertussigen is a membrane protein and is a good candidate for 
both a virulence factor and a hydrophobic component of the cell surface. 
The hydrophobic nature of pertussigen is suggested by reports of its 
association with lipid (Arai & Sato, 1976) and its insolubility in 
water (Irons & MacLennan, 1979b), The hydrophobicity of pertussigen 
could be determined by the retention of the purified protein on hydro- 
phobic gels. If found to be hydrophobic, then strains of B. pertussis 
differing in activities associated with pertussigen may differ in hydro­
phobicity, If this were so then pertussigen could be a contributary 
factor to cell surface hydrophobicity,
5, Effect of HA inhibitors on virulence
Cholesterol is an inhibitor of F-HA activity and haptoglobin 
inhibits the HA caused by pertussigen (irons & MacLennan, 1979a), These 
two inhibitors were used in virulence experiments although the hapto­
globin was not purified but used as Cohn fraction IV of human plasma,
which is rich in haptoglobin. The results (Tables 12&13) show that 
cholesterol had no inhibitory effect on challenges by either the i,c. or 
i,n. route, Cohn IV however reduced both i.e. and i.n. virulence of
12
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the strains used. As Cohn IV contained proteins other than haptoglobin, 
the significance of this result is less clear. It would be desirable to 
perform virulence and adhesion assays with purified haptolobin. If the 
purified material were to reduce virulence as did Cohn IV then it could 
act as a receptor for pertussigen vivo.
B. Adhesion to mouse lung
This adhesion system was devised to allow direct measurement 
of adhesion (or more accurately retention) in one of the virulence assays 
for B» pertussis, namely the sublethal i.n. assay. Whether the assay 
measures adhesion or if it is more accurately retention is not easily 
determined. It is not certain that B. pertussis actually physically 
adheres to the ciliated epithelium. This assay measures retention in 
mouse lung some of which may be adhesion. Therefore the results should 
not be interpreted as actual values for percentage adhesion but,com­
parisons between different levels of retention made. Adhesion however 
has been used throughout when referring to retention of B. pertussis in 
mouse lungs.
Two other factors must be considered when comparing levels of 
adhesion, these are (a) the possibility that the cells are killed and 
(b) the cells may be agglutinated in the mouse lung. Agglutination 
seems improbable as similar results were obtained in the time course 
experiments for both viable and radioactive counting methods, A 
killing effect is a possibility where the avirulent cells of B. pertussis 
(C mode and phase IVs) are killed more readily than virulent cells 
(X mode phase I cells).
The number of cells adhering increases for 30 min and this 
time was therefore used as the exposure time in most other experiments.
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However from Figs 7 and 8 adhesion appears to be biphasic with the rate 
over the first 2 min exposure being much greater than the rate after the 
first 2 min.
The idea that in any one culture of any strain of B. pertussis 
there exists only a proportion of the total number of organisms which 
are capable of adhering was expressed in the Results. This was 
suggested because different percentages of the inoculum were found to 
adhere in different experiments using different batches of the same 
strain. In one experiment (Table 22), using the same batch of cells,
10 fold increasing amounts of inoculum did not change the percentage 
of cells adhering. Electron microscope evidence supported the idea 
that only a fixed percentage of the cells would be expected to adhere 
since in all the static cultures examined only some of the cells were 
fimbriate. This correlation with the presence of fimbriae assumes 
that fimbriae are essential for adhesion. It would be of interest to 
re-inoculate organisms removed after the initial exposure to the lung 
into fresh lungs to determine levels of adhesion in this fraction of 
the original inoculum. This would tell whether all those organisms 
which can attach have already done so after 30 min in the lungs. With 
the viable counting method, variations in the percentage adhering on 
different occasions with the same strain could be accounted for if 
slight variations in culture affects the percentage able to adhere.
With the radioactive experiments, batches of labelled cells 
were grown and stored at -70°C. Therefore the same batch of labelled 
cells of each strain was used throughout the experiments. However 
there are obvious areas which could account for the variation in percent­
ages adhering for any one strain. The most important factor causing 
variation was the chemiluminescent effect caused by the tissue solubiliser, 
Soluene 350, Although vials were counted until consistent counts were
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obtained, vials left for several days in the dark before recounting 
showed a reduction in counts, in some cases dropping to very low percent­
ages indeed. The differences in adhesion levels were also greatly 
reduced in these instances.
It is probable that in a radiolabelled 5 day static culture, 
a considerable amount of the label was associated with dead cells and 
debris. Although the culture was washed, it is likely that label was 
present on dead cells. These labelled nonviable cells would interfere 
with calculations for levels of lung adhesion and also tend to mask any 
differences in adhesion of different cell types. Although much less 
convenient, the viable count method of assaying adhesion would avoid 
these complicating factors.
1. Inhibition of adhesion
The ability of prior vaccination of mice with either Glasgow 
standard vaccine or with F-HA (as LAP) to reduce adherence of B. pertussis
to mouse lung was examined. The standard vaccine which is a whole cell
vaccine showed little ability to inhibit adhesion (Tables 26 and 27),
The F-HA preparation administered either i,p, or i.n. 2 weeks prior to
adhesion assays being done on the mice caused reduced levels of
adherence of B. pertussis. Vaccination by the i.p. route appeared to 
be marginally more effective in reducing adhesion but this may simply 
reflect the larger amount of vaccine given by this route. Further 
experiments would be desirable with mice vaccinated i.n. repeatedly with 
F-HA to see if better inhibition of adhesion might be obtained. North 
& Anderson (1942) found that i.n, vaccination of mice gave better 
immunity to i.n. infection than I.p, vaccination. However solid 
immunity was only found when mice had been vaccinated several times,
A low-level sublethal i,n. infection was also found to
131
inhibit subsequent adhesion of B* pertussis to the mouse lung. This 
indicates that infection stimulates the production of local anti­
adhesion antibodies. However it is possible that the antibodies are 
not antiadhesive but rather act as opsins and therefore stimulate 
phagocytosis.
When the inoculum was mixed with whole static-grown cell 
antiserum, no reduction in adhesion was evident. When the inoculum was 
mixed with F-HA antiserum there was a reduction in the percentage of 
B. pertussis adhering to the mouse lung (Table 28), The ability of 
the two antisera to inhibit adhesion correlates with their different 
anti-HA titres (Table 17). This perhaps indicates that the reduction 
in adhesion after vaccination with F-HA is due to the production of 
antiadhesive antibodies,
2 o Adhesion of different strains
Cells with different virulence properties were examined for 
their ability to adhere to mouse lungs. Strain 18323 Xi.c. virulent, 
less i,n, virulent than strain 77/18319, which is avirulent i,c,), 
adhered less than strain 77/18319, This was expected as it had a 
lower cholesterol-sensitive HA titre than did 77/18319, In results 
nob presented here, the strain Taberman which was less virulent than 
strain 77/18319 showed a level of adhesion similar to strain 77/18319 
indicating that there is another factor involved in i,n, virulence 
additional to adhesion. This might, for example, be a factor that 
promoted the inflammatory response, leading to heightened consolidation 
of the lungs,
3. Effect of pH on adhesion
The effect of varying the pH of the adhesion assay was studied
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(Fig 9). Greater adherence occurred at pH 6„5 than at pH 7,0 or pH 8,0.
A pH value of 6,5 was chosen as at this pH the F-HA adhered to CM 
Sepharose CL6B indicating that at this pH it was positively charged.
If fimbriae are involved in overcoming the repulsive forces of like 
charged surfaces of bacteria and epithelial cells (it is assumed that 
these are both negative), then giving them a positive charge should 
increase the ability of the bacteria to adhere. It is impossible to 
know the exact pH at the lung surface where the B, pertussis cells 
adhere, however the pH of lung washing was found to be about pH 7,0.
It is possible that the pH at the epithelial surfaces may be slightly 
acidic due to the mucus and dissolved CO^, which would make adhesion of 
B. pertussis cells easier. With gonococci, a maximum level of adhesion 
was obtained between pH 5,5 and 7,0, The pH of maximum adhesion 
corresponded to the pH of the endocervix and male urethra,
4, Effect of F-HA inhibitor cholesterol on adhesion
The F-HA inhibitor cholesterol, which had no effect on i.n, or 
i,c, virulence also had no effect on bacterial adhesion to mouse lung 
(Table 28), There are two possible explanations for the ability of 
cholesterol to inhibit HA but not adhesion to mouse lung. These 
possibilities are (a) the cholesterol dispersions act as receptors for 
the fimbriae but they themselves have an affinity for epithelial cells 
which they do not have for erythrocytes hence causing indirect adhesion 
of B, pertussis to mouse lungs, or (b) cholesterol is not a receptor for 
the fimbriae but has an affinity for mammalian cells which causes the 
fimbrial receptors to be blocked. If proposal (b) were the case then 
this could explain the difference between HA inhibition and inhibition 
of adhesion to mouse lung. In the case of HA there is a limited number
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of erythrocytes present and the cholesterol present in the system may 
be sufficient to block enough receptor sitœ to inhibit HA, With the 
mouse lung adhesion system there should be a vast number of. receptors 
for F-HA present and the chance of the concentration of cholesterol 
present in the lung blocking all the receptors is very slight.
An experiment which would help in discerning whether or not 
cholesterol is a receptor for the F-HA would be to add radiolabelled 
cholesterol to a bacterial cell suspension which would then be centri­
fuged, If cholesterol is recovered with the cell pellet then it is 
probably attached to the bacteria via the fimbriae. If radiolabelled 
cholesterol is not recovered with the cell pellet, but when instilled 
into mouse lungs is found attached to the lungs it would seem unlikely 
that cholesterol is a receptor for the fimbriae,
Co Modulation, phase and colonial variation
Lacey (1960) showed that C mode cells had lost the HA, Since 
then it has been shown that B, pertussis has two HAs, a F-HA and a HA 
property associated with pertussigen (Arai & Sato, 1976), Pertussigen 
is lost during modulation as indicated by the loss of histamine 
sensitising and other activities (Parton & Wardlaw, 1974), In this 
study B, pertussis was grown in C modulating conditions in static 
culture, which stimulates production of fimbriae, but no HA ability was 
associated with 5-day cells. No fimbriae were observed by electron 
microscopy and no high molecular weight bands were found on SDS-PAGE of 
freeze dried culture supernate of C-mode cells (Plate 1), Under static 
conditions, the C-mode cultures did not grow as well nor form a surface 
pellicle like X-mode cultures; lack of a pellicle suggested a more 
hydrophilic cell surface in C-mode than in X-mode cells. Similar
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observations were made with both phase IV and large colony variants.
These three cell types (C mode, phase IV and large colony variants) had 
similar virulence properties (although phase IV was not tested here). 
Although C-mode and large variants lacked HA and fimbriae they were not 
completely avirulent. However the low virulence cannot be attributed 
solely to the lack of HA, as these variants are also deficient in other 
factors (Andersen, 1953; Wardlaw et al, 1975),
These three variant types were all compared to X-mode or 
phase I cells in the mouse lung adhesion system. All three showed a 
very marked reduction in the percentage of inoculum adhering which may 
explain their lower virulence. Although these cells are of low virulence 
a level of lung pathology is observed with C-mode and large colony 
cultures. It is possible that infection results from reversion in the 
lung to virulent X mode type. This seems likely in the case of C-mode 
cells since environmental factors in the culture induce C-modulation^ and 
the environment in the lung would not contain the high amounts of MgSO^ 
required to maintain the C-mode, However with both C-mode and large 
colony types it is possible that the lung pathology is caused by outgrowth 
of a constant low level of virulent, X-mode type organisms present in the 
cultures.
The nature of the interacting surfaces is important in adhesion. 
The bacterial cell, which is presumed to have a net negative charge has 
to come in close contact with the mammalian epithelial cell surface, 
which also has a net negative charge, to allow adhesion to occur.
Fimbriae from E, coli and N. gonorrhoea are thought to be hydrophobic 
(they have high levels of non-polar amino acids). It is possible that 
the hydrophobic nature of these appendages allows close contact between 
like charged cells by reducing the bacterial surface charge and conse-
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quently the mutual repulsion between the bacterium and the animal cell. 
The hydrophobic nature of the cell surfaces of C-mode, phase IV or the 
large colony variant was compared to that of X-mode cells. It was 
found that these variants were much less hydrophobic than X-mode, phase I 
small colony type cells insofar as they showed a much lower affinity for 
octyl-sepharose than did the virulent cell types. As has been discussed 
previously (p, 127 ) the low level of retention of B, pertussis C-mode
and phase IV cells on octyl sepharose would indicate not only the loss 
of fimbriae but the loss of other hydrophobic cell surface components. 
This is indicated by the level of retention of X-mode shake culture 
cells which although lower than X-mode static cells was higher than 
C-mode cells. The loss of hydrophobic'surface components in C-mode, 
phase IV and large colony type cells could be contributory to the 
reduced ability to adhere, by causing the cells to express higher net 
negative charge. This would increase the repulsive forces between the 
bacteria and the mouse lung epithelia.
Non-fimbriate, avirulent variants (type III and IV) of 
N« gonorrhoeae adhere as well as the fimbriate types I and II if the 
cells are pretreated to remove the negatively-charged carboxyl groups 
on the cell surface (Heck%ts et al, 1976), This suggested that the 
role of the fimbriae in this case was to overcome the repulsive forces 
between the bacterial surface and the surface of the cultured cells.
If fimbriae from B» pertussis are hydrophobic then they may reduce the 
cell surface charge and allow the cells to adhere, A preliminary 
experiment where the negatively charged carboxyl groups were removed 
from C-mode cells caused an increase .in their ability to adhere to 
mouse lung. This indicates that fimbriae are probably involved in 
overcoming repulsive forces of like-charged surfaces,
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Do Purification and protection
In recent years many attempts have been made to purify the 
protective antigen(s) of Bo pertussis. This has become of great 
importance as the number of children being vaccinated has decreased due 
to publicity about the risk of brain damage.
Various investigators have purified the components responsible 
for different pathophysiological activités; HSF (Lehrer ab, 1974, 1976), 
LPF (Morse & Morse, 1976; Sato £t al, 1974), HA (Sato, 1976), lAP 
(Yajima et al, 1978). These efforts eventually resulted in the 
suggestion that many of the toxic properties associated with B. pertussis 
were caused by a single component termed “pertussigen’*. The protective 
properties of these different fractions were tested in the mouse i.e. 
assay for pertussis vaccine potency (Kendrick ^  al, 1947) with much 
resultant controversy. An obvious problem with pertussigen is its 
toxic nature; indeed Pittman (1979) proposed that pertussigen or 
pertussis toxin (name preferred by Pittman) is the toxic factor in the 
disease. It would be expected that, if pertussigen was the toxic 
factor responsible for disease symptoms, that antitoxin would be protect­
ive in man, and if the mouse i,c, model assays human virulence, pertuss­
igen would be protective. However according to Sato ejt ad (1979) and 
Irons & MacLennan (1979a) prior vaccination with pertussigen afforded no 
protection against i,c, challenge in mice.
In the study of Sato et ad (1979) pertussigen had been toxoided ■ 
with formaldehyde and found not to be protective. Irons & MacLennan 
(1979a) used native pertussigen which they found to be toxic at higher 
levels and not protective at lower non-toxic levels. In contrast 
Munoz eb (1981) reported that vaccination with pertussigen protected 
mice against i.e. challenge. It is possible that the toxoiding
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procedure used by Sato e_t ad (1979) destroyed the protective activity 
of the pertussigen.
The results obtained in the present study agree with those of 
Munoz ^  ^  (1981) in that a fraction LSP with high HSF activity, which 
was toxic,■showed protection against i.c, challenge at lower, non-toxic 
levels. In addition vaccination with LAPcontaining mainly the F-HA 
also conferred protection against i,c. challenge. This indicates the 
presence of two protective factors. From SDS-PAGE and histamine 
sensitisation tests both fractions are cross-contaminated. However the 
levels of contamination do not account for their protective properties; 
the PD^Q value of the hAP (F-HA) corresponded to approximately 4,8 pg 
but the HSD^q value for the preparation was about 19 pg (Tables and 
lé'). With the LSP (pertussigen) the protective dose was approximately 
4 to 5 HSD^Qg. Similarly the level of protein giving protection in 
the pertussigen preparation was only 0.88 pg compared with 4,8 pg for 
the F-HA preparation. From these figures it is clear that protection 
conferred by the F-HA could not be due to contaminating pertussigen 
and vice versa, therefore there are at least two protective factors,
Munoz _et ajL (1981) suggested that the protection noted with 
F-HA preparations was dependent on the presence of small amounts of 
pertussigen, possibly acting as an adjuvant, as they found that F-HA 
preparations with no detectable pertussigen activity were not protective. 
Since the F-HA preparation used in these experiments was partly contam­
inated with pertussigen then this explanation may be applicable. They
/
also suggested that since pertussigen was a poorer antigen than 
F-HA in the presence of F-HA pertussigen became highly effective. The 
results obtained in this study disagree with this proposal. Both F-HA 
and pertussigen are cross-contaminated therefore the pertussigen
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fraction should be highly effective due to the presence of F-HA, The 
effectiveness of the pertussigen in the presence of F-HA cannot account 
for the level of protective activity associated with the F-HA preparation. 
The LAP was used to raise rabbit anti F-HA antisera. The 
ability of the two F-HA antisera to inhibit HA was shown (Table 13),
One serum (2) was very poor, showing approximately the same ability to 
inhibit HA as did whole cell antiserum. However F-HA antiserum (2) 
showed different abilities to passively protect mice against i.c, challenge 
than whole cell antiserum (Table 21), F-HA antiserum (2) was not 
protective, F-HA antiserum (1) had a higher HAI titre than F-HA
antiserum (2), whole cell antiserum to strain 77/18319 or the US 
standard antiserum, F-HA antiserum (1) was protective against i,c, 
challenge but not to the same extent as the two whole cell antisera.
These results show that although anti F-HA may be protective it is not 
the major protective factor against i,c, challenge in whole cell antiserum, 
F-HA antiserum (1) was also used in studies of passive 
protection against i,n„ infection. Even at a 1/50 dilution of the 
antiserum a significant reduction in lung pathology was observed. The 
whole cell antiserum to strain 77/18319 also showed passive protective 
activity against lung infection but this antiserum was not titrated here. 
The passive protection results indicate that the F-HA antiserum was a 
much better protective agent against lung infection than against i,c, 
infection. This would seem to be true for other antisera including 
the US standard antiserum (L,Q , Stevenson, personal communication).
To check that the protection afforded by the F-HA antiserum (1) 
was not due to antibodies to contaminating pertussigen, an anti-HSF 
assay was done. When mice were injected with 1 HSD^^ mixed 1:1 with 
undiluted F-HA antiserum (1) no reduction in deaths was observed when
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the mice were challenged with 3 mg of histamine 5 days later (Table 20),
This indicated either no or a low level of anti-pertussigen activity in 
the antiserum. However it cannot be concluded that protection was due 
only to anti-F-HA activity, as many more antibodies would be required to 
neutralise the large mass of bacterial substance involved in an HSF test, 
than to neutralise infection. Therefore there may be antibodies to 
pertussigen present in the antiserum.
With whole-cell antiserum, it is obvious that there are 
protective factors involved other than anti-HA activity, since the level 
of protection afforded by a whole-cell antiserum is not directly related 
to its anti-HA activity. What these other protective antibodies are 
directed against is not known. However the results (Table 20) show 
that whole cell antiserum to strain 77/18319 contains anti-HSF activity.
Recently Sato eb ab (1980) described an aerosol infection assay 
similar to the sublethal i,n, infection used in this study. In the aero­
sol infection, mice were kept in a sealed box and the atmosphere sprayed 
with droplets containing B. pertussis (Sato, 1980), Using this system 
Sato e_t ab (1981) showed that antiserum raised against pertussigen with no 
detectable antibodies to F-HA, protected mice against i.e. challenge,
Munoz e_t ^  (1981) also showed that antiserum to pertussigen with no 
detectable antibodies to F-HA, protected mice against i,c. challenge.
They also obtained protection against i.e. challenge with a mixed antiserum 
(antiserum to pertussigen and F-HA) but not with an antiserum raised against 
pure F-HA, In this present study a low level of passive protective activity 
against i,c, challenge was found with F-HA antiserum. There are differences 
in the method used by Munoz e^ ab (1981) and this present study in determ­
ining the passive protective activity of the F-HA antiserum, Munoz ^  ^  
(1981) administered the antiserum i,p, 2 h before i.e. challenge. In this 
study the challenge was mixed with the F-HA antiserum before being
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injected ioC, into the mice. With the method used here it is possible 
that the protective activity of the F-HA antiserum was not specific.
This possibility was suggested by the ability of normal serum to reduce 
the hydrophobicity of static X-mode B, pertussis cells as much as F-HA 
antiserum. This might cause a reduction in the ability of the cells to 
adhere and therefore reduce infection. Normal serum was not tested 
here for ability to reduce i,Co virulence, but the results of the anti­
adhesion assays support a specific effect since F-HA antiserum reduced 
the adhesion to mouse lung to a greater extent than whole cell antiserum 
to strain 77/18319,
In the method used by, Munoz al_ (1981) any non-specific 
reaction can be discounted as the antiserum is administered separately 
from the i.c, challenge, via fhe i,p, route. However there are 
possible explanations for the lack of protection observed with their 
F-HA antiserum. The antiserum was administered i,p, and therefore 
would have to reach the site of infection via the blood. This would 
require the breakdown of the blood brain barrier which may take several 
days (Dolby & Standfast, 196.1), This means that the antibody to the 
F-HA is unlikely to be present in the brain when the infecting bacteria 
first encounter brain substance. The longer the delay in the antibodies 
reaching the site of infection the less likely antiadhesive antibodies 
are liable to be effective. This is particularly true for fimbrial 
adhesion which may only be a transient stage before closer cell-cell 
contact is established.
From the evidence presented by other workers (Sato ^  al, 1979; 
Irons & MacLennan, 1979a) and the results obtained in this study it seems 
that F-HA is a protective antigen. However from this study it would 
seem to be less effective than pertussigen, therefore further work should
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focus on producing a detoxified pertussigen antigen while maintaining 
its protective properties.
No work has been done on the serospecificity of the F-HA from 
different strains of B. pertussis. The antigenic differences in 
fimbriae from N. gonorrhoeae, have caused problems for production of a 
fimbrial vaccine. Before a vaccine is prepared using the F-HA, this 
area should be investigated. In this study the F-HA was derived from 
strain 77/18319 yet protected against an i.c. challenge with strain 
18323, Also antiserum raised from the F-HA preparation protected 
against sublethal i,n, infection with strain 18334, These preliminary 
results may indicate that the F-HA of different strains are antigenically 
similar. However the protective activity against further strains 
would have to be tested in order to generalize,
E, Conclusions and perspectives
1, Proposed model for adhesion
The following model for adhesion of B, pertussis is suggested 
by the present results together with other information. However some 
of the results do not fit the model but further experiments are 
suggested for resolving inconsistencies.
It is suggested that (1) fimbriae promote rapid adhesion 
through their hydrophobic structure which may interact with similarly 
hydrophobic structures on the mammalian cell, or simply mask the 
negative charge of the bacteria, thereby allowing the bacteria to 
approach the epithelial cell surface. The results from HIC and mouse 
protection experiments support this idea, (2) The epithelial cell 
receptor for the fimbriae is not cholesterol as suggested by its ability
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to inhibit HA activity (Irons & MacLennan, 1979a; Sato £t al, 1979),
Î . ■
Probable explanations for the cholesterol inhibition of HA but not 
adhesion or virulence were discussed and further experiments which could 
help clarify the situation were also suggested (p, 134 ). Also the
abundance of cholesterol in mammalian cells would make the specificity 
of B...pertussis for ciliated epithelial cells., difficult to explain,
(3) After the initial adhesion between the bacterial cell and the epi­
thelial cell via the fimbriae, a second adhesion involving an outer 
membrane protein may operate, (4) This second adhesion step may 
facilitate the transfer of toxic factors, including pertussigen, from 
the bacterium to the mouse epithelium, (5) This secondary adhesion 
may occur more slowly than the first. Therefore non-fimbriate cells 
would be less effective in adhesion and consequently of lower virulence. 
There is some evidence to support this secondary adhesion 
hypothesis (a) the ability of the haptoglobin-containing Cohn fraction 
IV of plasma to reduce the lung pathology in sublethal i,n, virulence 
experiments, (b) the ability of bacteria of strain 18323 with a low 
cholesterol-sensitive HA content to adhere, (c) the lack of protection 
conferred by F-HA antiserum when administered i,p, before challenge, 
which would delay its contact with the infecting bacteria (Munoz e_t al, 
1981) and (d) if cholesterol is the receptor for the fimbriae then a 
second adhesion may provide the specificity of attachment site shown by 
the B. pertussis cells (Hopewell e_t al, 1972; Muse e_t 1977),
The ability of B. pertussis to adhere to epithelial cells 
would seem to be more important for virulence in the mouse lung, than 
in Intracranial infections. In the lung larger numbers of organisms 
are required for severe lung pathology, than with the i,c, infection 
where only a few virulent organisms are sufficient for death of the
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mouse to occur. As the human disease involves the respiratory tract, 
adhesion should be important as a method of by-passing the mucociliary 
clearance mechanisms. To understand the adhesion mechanism(s) is 
important if antiadhesive activity is to be used for protection. It 
would also be important to investigate the production of antiadhesion
antibodies in the lung secretions. However there would be no point in
injecting children with an antiadhesion vaccine if the antibodies remain 
in the serum. Efficient methods of producing a local antibody response 
should be further investigated.
2, Proposed future work
From the results in this study and the subsequent discussion 
there is evidence for an adhesion role for fimbriae in lung infections, 
but there is also the likelihood of a second adhesion mechanism being 
involved. Future work should include the search for F-HA negative 
mutants which have high levels of pertussigen. This would enable 
further clarification of the role of fimbriae in adhesion without the 
complication of possible regeneration of fimbriae as is the case with 
X-mode shake cultures. Adhesion studies should also be done on strains 
with constant fimbrial endowment but different pertussigen content.
This might be achieved by screening strains for constant F-HA but
widely different HSF activity. These experiments might show whether 
the level of pertussigen, which has HA activity, affects adhesion and 
would therefore be a candidate for a secondary adhesion mechanism.
Identification of the receptors for B. pertussis might help 
elucidate the possible role of cholesterol in adhesion. Purified 
haptoglobin should also be used in adhesion and virulence assays to see 
whether it inhibits these systems.
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Another important point is the actual production of fimbriae.
Do shaken cells lacking fimbriae produce the appendages in the mouse 
lung? This would seem to be so as these bacteria are virulent, and 
the virulence is protected against by F-HA antiserum. Electron 
microscope examination of organisms before infecting mouse lungs, and 
organisms removed from mice with lung pathology should help in determining 
whether or not the fimbriae are regenerated. Some vitro experiments, 
where shaken cells or blended static cells, are transferred to fresh 
medium incubated statically, sampled and examined in the electron micro­
scope could reveal the time needed for regeneration of fimbriae. Such 
a study has already been done with E, coli (Novotny £t ad, 1969),
F-HA is worthy of serious consideration as a component of a 
future improved pertussis vaccine with detoxified pertussigen as a 
second component. If F-HA is to be used in this way the purification 
method described here is simple and removes most of the toxic activity. 
Also there would seem no need to remove the F-HA as it seems to be a 
potent antigen when attached to the liposomes.
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APPENDICES
Appendix 1 - Liquid Culture Media (10 litre)
Components of 
Hornibrook*s (g)
Sato et al (1974) (g)
X medium
Cas amino Acids
(Difco Technical)
CaCl^, anhyd,
CuSO^ SH^O 
cysteine HCl 
FeSO^ 7H20^
Glutamic Acid 
Glutathione^
KCl
KHgPO^ anhyd 
K^HPO^ anhyd 
MgSO^ 7H2O 
MgCl^ 6H^0 
Nicotinamide 
NaCl
Soluble Starch^
Tris(hydroxymethyl)amino- 
me thane
100
0.02
0.1
2
2.5
0.25
0.01
50
10
C medium X medium C medium
100
0.02
0.1
2
2.5
50
0.25
0.01
10
100
0.1
0.0075
0.3
0.1
2
0.1
4
0.3
25
15
60.7
100
0.1
0.0075
0.3
0.1
2
0.1
25
4
0.3
15
60.7
All the components of the media except those labelled 1 are dissolved in
distilled water and the pH adjusted to 7.2 with Na C0„ in the case of
2 3
Hornibrook*s medium and HCl in the case of Sato e2 al medium. The com­
ponents labelled 1 are dissolved in water, filter sterilized and then 
added just before use. The starch (2) is dissolved in boiling water 
before adding it to the bulk of the medium before sterilisation.
A1
Appendix 2 - Diluents
17o Casamino Acids (C.A.D.) 1 litre - Cas amino Acids (Difco) 10 g
Mgci^ 0.1 g
CaCI^ 0.016 g
NaCl 5 g
Adjust to pH 7.1 with l.OM NaOH
Phosphate Buffered Saline (PBS) 1 litre - NaCl 8 g
KH^PO^ 0.34 g
K^HPO^ 1.21 g
A2
Appendix 3 - Gels and Buffer for P.AoG.E,
STOCK SOLUTIONS
lo Acrylamide.(BoD.Ho) 30.0 g )
) made up to 100 ml 
NN'methylenebisacrylamide (NN*bis) 0.8 g)
2. Running buffer (lOx) pH 8.8 
glycine 
Tris
144.13 g)
1*0 made up to 1 litre
30.28 g)
3o Solubilizing buffer 
0.5M Tris/HGl pH 6.8 
207. SDS w/v 
P mercaptoethanol 
glycerol
0 .1% bromophenol blue w/v
H^ O
25 ml 
20 ml 
10 ml 
20 ml 
2 ml 
23 ml
4. Staining Solution
Coomassie Brilliant Blue R (Sigma) 1.25 g
t
507) Methanol 454 ml
glacial acetic acid 46 ml
5. Destaining solution 
Methanol 
Acetic Acid
H^ O
50 ml 
75 ml 
875 ml
Gels were run in l/lO dilution of running buffer at a constant current 
of 15 mA for approximately 3 h, in a Shandon analytical PAGE outfit 
(Shandon Southern Instruments Ltd., Surrey, England).
A3
Sample Preparation
-1 *
Protein samples (approximately 200 pg ml ) were mixed 1:1 with 
solubilizing buffer and heated at 100°C for 5
Gel Preparation
(a) Separating gel (11% acrylamide)
Acrylamide/NN*bis 36.7 ml
IM Tris/HCl buffer pH 8.8 37,5 ml
20% (w/v) SDS 0.5 ml
TEMED 25 pi
Ammonium persulphate 0.8% w/v
(freshly prepared) 10 ml
H^O 15.3 ml
(b) Stacking gel (5% acrylamide)
Acrylamide/NN*bis 16.7 ml
0.5M Tris/HCl buffer pH 6.8 25 ml
20% w/v SDS 0.5 ml
TEMED 25 pi
Ammonium persulphate 0.8% w/v 10 ml
H^O 47.8 ml .
* - This was only the case when possible with the pertussigen
preparation the protein concentration was much lower.
A4
Appendix 4
Triton-Toluene Scintillant
Triton X-100 1 litre
Toluene (technical grade) 2 litres
2,5-Diphenyloxazole 8 g
l,4-Di-2-(4-methyl-5 phenyl-
oxazolyl benzene 0.2 g
A5
